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The development of the central nervous system requires the orchestration of
numerous instructive and permissive cues. These factors are secreted from
signaling centers and function in a concentration dependent manner that effects
the proliferation, survival and differentiation of neural progenitors (NP) and their
differentiated progeny. The family including bone morphogenetic proteins (BMPs)
are key regulators of NP expansion and survival. However, once NP become
committed to a neuronal fate and begin to differentiate they compete for limited
amounts of neurotrophin that facilitate further growth and survival. Here we show
that the p75 neurotrophin receptor interacting protein NRAGE is expressed in NP
of the developing cortex during the peak period of progenitor apoptosis. This
NRAGE dependent apoptosis of NP cells is mediated through the BMP TAKITABI-XIAP signaling complex leading to the activation of p38. The combined
BMP activation of p38 and Smad signaling adversely effects the terminal
differentiation of NPs into neurons. These results demonstrate the conserved

nature of progenitor and trophic dependent apoptosis through the utilization of
NRAGE and common cell death machinery highlighting the important
mulitfunctionality of NRAGE during neurogenesis.
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CHAPTER 1
Introduction t o Apoptosis and Developmental Neurobiology.
Morpholoqical Types of Cell Death.
It has been proposed that there are three main types of cell death during
normal development, on the basis of the role of the lysosomes in cell disruption'.
In the first type, cell death occurs without any detectable activities of endogenous
lysosomes and secondary lysosome activation by tissue macrophages. This
process has been referred to as heterophagocytosis. In the second type of cell
death, autophagocytosis cells are eliminated after activation of their own
lysosomal enzymes. In the third type, there is no obvious lysosomal intervention.
The first types are by far more common and have been described by various
authors2.
Apoptosis.
Apoptosis was originally defined as a distinct mode of cell death on
the basis of a series of characteristic ultrastructure features according to the
following sequence of events: nuclear and cytoplasmic condensation, cell
fragmentation and phagocytosis3.However, more recent attempts to characterize
apoptosis have included cell dehydration, cell membrane changes, condensation
of nuclear chromatin, disintegration of the nuclear envelope, mobilization of
intracellular ionized calcium, a decrease of the mitochondria1 transmembrane
potential, activation of caspases, and internucleosomal DNA cleavage.
Therefore, a wide spectrum of methods has been developed to assess and
quantify apoptosis in biological systems. Late apoptotic events such as DNA-

strand breaks can be assessed by terminal deoxynucleotidyl transferases (TdT)
assays or nuclear DNA fragmentation of cells with sub G I DNA content. More
recently redistribution of the phospholipid phosphatidylserine (PS) from the inner
plasma membrane leaflet to the outer leaflet has been used to determine early
apoptotic events4. Following apoptotic cell fragmentation into membrane-bound
bodies macrophages or neighboring cells rapidly clear out and degrade apoptotic
bodies within heterophagosomes.
The process of apoptosis plays an essential role in sculpting parts of the
body. The formation of digits in some higher vertebrates is a well-studied
example, where apoptosis eliminates the cells between developing digits5-'.
Similarly, apoptosis is involved in hollowing out sold structures to create lumina.
In the early mouse embryo, for example the preamniotic cavity is formed by the
death of ectodermal cells in the core of the developing embryo8. Apoptosis also
occurs wherever epithelial sheets invaginate and pinch off to form tubes or
vesicles, as in the formation of the neural tube, lens and mammalian palateg.
In the course of animal development, various structures are formed that
are later removed by apoptosis. These include transient structures that are
needed at one developmental stage but not at a later or structures required in
one sex but not the other1'. However, one of the most perplexing phenomena
,that involve apoptosis is the overproduction of cells within a given tissue and then
subsequent culling by apoptosis to adjust their numbers. In the vertebrate
nervous system both neurons and oligodendrocytes are generated in excess with
a large percentage being eliminated by programmed cell death11312.Although the

influence of cell proliferation in controlling cell numbers in animal development
has received more attention the influence of apoptosis may very well be a
dominant mechanism an its role during neurogenesis is an important new
frontier.

Cell Death i n Early Neural Development.
Programmed cell death is a highly phylogenetically conserved mechanism

by which eukaryotic cells die following a stereotypic series of molecular and
cellular events commonly referred to as a p o p t o s i ~ ~
Apoptosis
~~~.
has been
recognized to be an essential process during development where it appears to
be fundamental for the control of the final numbers of neurons and glia in the
central nervous system (CNS) and peripheral nervous system (PNS). Moreover,
a growing body of evidence indicates that apoptosis is also responsible for the
loss of neurons associated with physiological aging14,15.
Nearly all classes of neurons are produced in excess during development
and it has been postulated that approximately half die before the completion of
the CNS'~.These large populations of neurons are then significantly reduced
during the periods of naturally occurring neuronal death, primarily through
activation of the apoptotic machinery. The neurotrophic theory clearly establishes
the role of target-derived neurotrophic factors in the protection of projecting
neurons from programmed cell death. The neurotrophic theory provides a
conceptual base for the acceptance of cell death as a physiological process in

neural development, but also to generalize the significance of cell death during
normal development in an
Still, the general idea beyond this expanded concept is that naturally
occurring neuronal death is closely related to the establishment of proper
connections with their target, and under this perspective little attention has been
dedicated to apoptosis of neural precursors andlor young neuroblasts at early
developmental stages, which seems to be independent from synaptogenesis.
Early Death of Proliferating Precursor Cells.
It is generally believed that a correct balance between cell
proliferation and apoptosis during development is fundamental to determining the
ultimate structure, architecture, size, and shape of tissues and organs. The
existence of naturally occurring cell death in the neuroepithelium at the beginning
of neurulation was first described more than 50 years agog. Since then early
neural death has been described during the formation of neural crest, and
neurogenesis, with a widespread distribution through out the CNS and in PNS
In these early developmental stages, differentiated neurons are
rare, if not totally absent. Therefore, although a quantitative contribution of early
progenitor apoptosis has been elusive, it is reasonable to assume that they must
be proliferating neural precursors or newly generated neuroblasts and not
functional neurons connected to their targets.
Studies utilizing knockout mice studies have provided dramatic proof of
the occurrence of cell death during early neural vertebrate development in which
activation of several regulatory or executor molecules in the apoptotic pathway

caused embryonic or perinatal

Unexpectedly, the CNS was the most

affected tissue, presenting a large excess of neurons in disorganized structures.
Morphological defects were already visible well before neuronal generation, as
early as embryonic day (E) 9.5 in the null mutant for the apoptotic activator Apafand at E l 0.5 in the null mutants for caspase-932and caspase-333.
Since proliferation, differentiation and apoptosis are concurrent processes
during early neurogenesis, determination of the relationship between proliferation
and apoptosis of individual cells is an important issue to be assessed.
Interestingly, a number of studies led to the conclusion that apoptotic cells enter
the cell cycle shortly before

Making the relationship between cell

cycle control and apoptosis a vital mechanism in controlling cell fate.
Neural Apoptosis at Cell Cycle Checkpoints.
The cell cycle apparatus is composed primarily of three families of
proteins: the cyclin-dependent protein kinases (CDKs), the cyclins and the cyclindependent kinase inhibitors ( ~ ~ 1 s CDKs
) ~ ~allow
~ ~ progression
~ .
through the
different phases of the cell cycle by phosphorylating critical serines and
threonines on their target substrates. Their kinase activity is dependent on the
presence of activating subunits known as cyclins, whose abundance varies
substantially during the cell cycle. D-type cyclins are rapidly turned over and are
synthesized in response to mitogenic stimuli. Once synthesized, they associate
with CDK4 and CDKG, forming active CDK complexes in early G1 phase40141.
In
midllate G I , cyclin E is induced and forms complexes with CDK2, whose activity
Cyclin A activity appears in
appears essential for entrance into S phase42s43.

concert with the onset of DNA synthesis and it initially partners with CDK2 and
~ mitosis
~ ~ ~ to~occur,
.
cells must progress through the G2lM
later with C D C ~ For
transition, which requires the assembly of the maturation-promoting factor (MPF)
that is composed of cyclin B and CDC2. At late G2, MPF induces its own demise
by activating the mitotic cyclin destruction system through the anaphasepromoting complex (APC), which acts as a ubiquitin E3 ligase for MPF.
Two major classes of CKls have been identified. The first is the Kip family
of inhibitors that consists of p21Waf1,~ 2 7 and
~ ~~ ~5 7
' ~These
' ~ ~three
.
CKls can
bind to most cyclin-CDKs and inhibit their a ~ t i v i t i e s ~The
~ - ~ ~Kip
. family of
inhibitors share a common N-terminal domain for binding to and inhibiting the
kinase activity of CDK-cyclin complexes. The second family of CKls consists of
the INK4 family of inhibitors, which includes p16INK4al p151NK4b, p181NK4~, and
~ 1 9 'INK4
~ ~proteins
~ ~ . are a group of ankyrin repeat-containing proteins, which
specifically bind to and inactivate CDK4 and CDK6 by preventing their bindings
tothecyclins49,50 .
The orderly progression of the cell cycle is driven by sequential activation
of CDKs to pass key restriction or

primarily during the GIIS and

G21M transition of the cell cycle. The checkpoints of the cell cycle ensure that
critical events in a particular phase are completed before the next phase can be
initiated, thereby ensuring genome integrity. Frequently, cells decide to enter or
withdraw from the cell cycle at the G I phase, and thus the G I checkpoint at the
GI/S transition is often a prime target for cell cycle regulation. Cell cycle

progression can be blocked at the G I checkpoint in response to the status of
both the intracellular and extracellular environments.
G I phase is a period when cells make critical decisions about their fate,
including the option to replicate DNA and complete cell division. The decision to
enter the S phase is made at the so-called restriction point in mid-to-late ~ 1 ' ~ .
The genes critical for G l / S transition and coordination of S-G2-M progression are
regulated by the parallel retinoblastoma protein (Rb) and Myc pathways54.
Retinoblastoma Protein Family.
Among the best-characterized substrates of G I CDKs are Rb and
the Rb-related proteins p107 and p13055-57.Each of these Rb family members is
capable of blocking progression from G I into

s

~suggesting
~ - some
~ ~functional

redundancy amongst Rb family members. When hypophosphorylated, Rb is
active and able to bind to and repress transcription factors that promote
proliferation,

most

notably,

the

E2F

family

of

transcription

factors.

Phosphorylation primarily through CDK activity inactivates Rb, thereby releasing
these transcription factors and driving S phase progression. Rb-deficient
embryos display numerous abnormalities in the nervous system, which occur
shortly after the time at which Rb would normally be expressed. In ~ b - 'null
- mice
ectopic mitosis is observed in various brain regions and massive cell death
occurs throughout the CNS and P N S ~ ~A- transient
~~.
increase in Rb protein
levels appear to be an important step in the initiation of terminal mitosis of
neuronal progenitors, and is then followed by drastic reduction during terminal
Moreover,
differentiation and maintained at low levels in postmitotic neurons67s68.

an increasing body of evidence is leading to the notion that postmitotic neurons
generally undergo apoptosis when the cell cycle regulators that promote Rb
phosphorylation are activated. In support of this, E2F family members can trigger
apoptosis, and E2F1-induced apoptosis can be specifically inhibited by ~ b ~ ' .
High levels of E2F1 in a cycling cell signals division, in a quiescent cell such as a
postmitotic neuron, the potent contradictory growth signals of E2F1 above a
critical concentration may trigger the apoptotic cascade. The E2F1-mediated cell
death of neural progenitors appears due to Rb-inactivation and was shown to be
p53-dependent70771.

Death of Postmitotic Neurons.
Neurotrophins and Neuronal Survival.
Death of postmitotic neurons is a widely recognized phenomenon
that plays a crucial role in sculpting and maintaining the architecture of the
mature nervous system. A relatively large apoptotic loss of different types of
neurons (and glial) occurs during vertebrate development, and the general
explanation for this phenomenon is that survival of nerve cells depends on
specific neurotrophic factors which are synthesized by their targets72-74 .
Therefore, although many neuronal types are produced in excess, only a portion
of them receives sufficient proper support for survival.
Nerve growth factor (NGF) was the first in a family of small soluble
molecules demonstrating survival effects on populations of mature neurons both
in vitro and in vivo. The effects of these neurotrophic molecules are mediated

through two distinct classes of receptors. One class consists of members of the
Trk family of tyrosine kinase receptors while the other is made of a single
member, ~ 7 5 Decades
~ ~ ~of biochemical
.
analyses have resulted in great strides
towards understanding NGF signaling potential through Trk and recently through
~ 7 5I began
~ ~ my
~ studies
.
attempting to understand the biological and signaling
potential of

by examining the expression and role of

interacting

proteins. My studies culminated with the discovery that one such interacting
protein, NRAGE is expressed in a wide variety of tissues throughout
development in a tight temporally regulated manner.
Neurotrophins and Neurotrophin Signaling.
The neurotrophins are a family of structurally related proteins. Four
neurotrophin genes have been identified in both mouse and humans. Each gene
codes for secretory proteins sharing four hallmark characteristics: (i) biosynthesis
as precursor proteins, (ii) characteristic spacing between their six cysteine
residues, (iii) highly basic isoelectric points, and (iv) the formation of noncovalently bound homodimers72-77 . Following the discovery of nerve growth factor
( N G F ) ~ ~ ,binding
~',
studies with radiolabeled NGF suggested the presence of two
different receptors on responsive cells: one with high affinity and slow kinetics of
association/dissociation and one with relatively low affinity and fast kineticsB0.
The gene encoding for the low-affinity NGF receptor was the first NGF receptor
to be cloned. Moreover, the primary sequence of its cytoplasmic domain did not
indicate any catalytic activity, nor was this receptor sufficient to account for the
physiological survival effects mediated by N G F ~ ' , ~Following
*.
the identification of

brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin
415 (NT4/5), these neurotrophins were also shown to bind to ~
similar to that of NGF (about

7 with5affinities
~

~

lom9M), but with relatively slower kinetic^'^‘^^. This

observation lead to a nomenclature change for the low-affinity NGF receptor to
reflect its wide range of physiological relevant ligands. The low-affinity NGF
receptor is now commonly referred to as p75 neurotrophin receptor ( ~ 7 5 ~ ~ ~ ) .
After

the

initial

biochemical characterization of

p75NTR, it was

demonstrated that the proto-oncogene TrkA (tropomyosin-related kinase) had an
expression pattern in the developing nervous system suggestive of a potential
role in neural development. It was hypothesized that TrkA may mediate long-term
NGF survival87. Independent studies soon demonstrated that TrkA bound NGF
resulting in the activation of its intrinsic tyrosine kinase promoting long-term
Kinetic and binding experiments demonstrated that this second NGF
receptor binds NGF with high-affinity75. One family of highly related tyrosine
kinase receptors is now recognized in mammals, each receptor selectively
binding

its

cognate

neurotrophin(s)

inducing

dimerization

bring

their

cytoplasmically located tyrosine kinase activities into proximity, thereby inducing
them to cross-phosphorylate. Each receptor, TrkA, TrkB, and TrkC, is expressed
in distinct parts of the nervous system and in several i s o f o r m ~ ~NGF
~ * ~is~ the
.
preferred ligand for TrkA, BDNF and NT415 are preferred for TrkB, and NT3 for
~ r k ~ ' *Ligand
.
binding triggers receptor dimerization, autophosphorylation, and
activation of well-characterized signal transduction pathways that includes

~

phosphatidylinositol 3 kinase, phospholipase C, and the RasIMAP kinase
cascade93,94 .
A plethora of experiments have demonstrated that the Trks mediate
100-102, synaptic plasticitylo3s u r v i v a ~ ~p ~
r o~l~i f~e, r a t i ~ n ~overt
~ ~ ~differentiation
~~~~,

'05, dendritic and axonal ~ p r o u t i n g ' ~neurotransmitter
~-~~~,
expression and longterm p~tentiation'~~-''~.
However, some of the most convincing evidence comes
from the tight correlation between the nature and the extent of neural losses after
deletion of either a Trk receptor or its corresponding neurotrophin gene1'*.
Neurotrophin Withdrawal and Apoptosis.

The first neurotrophin-activated signaling protein shown to mediate
survival of neurons was the small GTP-binding protein Ras. Inhibition of Ras
activity decreased of survival many neuronal p ~ p u l a t i o n s ' ' ~ Ras,
- ~ ~ ~which
.
in
most cases is responsible for 40-60% of neurotrophin-dependent survival, does
not act directly to promote survival. Rather, it functions by translating and
directing

neurotrophin-initiated signals

into

multiple signaling

pathways.

Numerous studies indicate that the two signaling pathways, PI-3WAkt and
MEWMAPK, are the major effectors of neurotrophin and Ras-activated survival.
PI-3K was first identified as a regulator of neurotrophin mediated survival
responses by Cooper and colleagues in NGF-dependent PC12 cells"5.
Subsequently, many groups showed that PI-3K activity was responsible for as
much as 80% of neurotrophin regulated cell survival in cortical, cerebellar, motor,
sympathetic and sensory

neuron^"^-'^^.

Ras was shown to activate PI-3K

survival promoting pathways through common effector proteins. Ras is not,

however, the only means by which Trk activates PI-3K. In the Trk system, PI-3K
activation is due to the corrtbined actions of Ras and Gab-I 127,128. The primary
target for active PI-3K appears to be the serinelthreonine kinase ~

k

t Akt ~

promotes its pro-survival activity through the phosphorylation of Bad that
facilitates an association with 14-3-3, preventing it from binding and inactivating
the anti-apoptotic protein Bcl-2 and Bcl-XL131,132. Another potential target of PI-3K
is the IAP (inhibitor of apoptosis) family of caspase inhibitors, which include Xlinked inhibitor of apoptosis (XIAP), neuronal apoptosis-inhibitory protein (NIAP),
and human inhibitor of apoptosis protein (HIAP) that function through inhibitory
associations with procaspase-9133.
Neurotrophin withdrawal reduces the activity of PI-3K permitting BH3
containing proteins, such as Bad and Bcl-2, form a mitochondria1 pore increasing
cytochrome c release and the activation of procaspase-9, which serves as a
convergence in molecular pathways of apoptosis signaling formation of the
apoptosome with subsequent cleavage of caspase-3 to the active form providing
an unfettered route to apopt~sis'~.
Although the role of the Trk receptors has continued to be thoroughly
investigated and the function of the other neurotrophin receptor, p75NTR,has
been more difficult to ascertain due to its lack of any obvious intrinsic catalytic
activity or signaling domains. Complicating the issue, p7kjNTRis often coexpressed with at least one Trk receptor family member, making independent
study of ~ 7 5 ~ ~ ~ - m e d i effects
a t e d difficult. However, recent studies indicate that
does in fact have intrinsic signaling functions as described below.

~

~

~

~

7 as a5Death
~ Receptor.
~
~
In addition to the ability of ~

7 to modulate
5
~ the
~ binding
~
and

function of Trk receptors, this receptor has unique functions when expressed in
the absence of Trk. The identification of p75NTRas a member of the TNF receptor
superfamily suggests that ~

7 might
5 signal
~
cells
~
to~ die, possibly using an

analogous mechanism to TNF signaling. The first demonstration that ~

7

5

~

5

~

could mediate apoptosis was by Rabizadeh and c o ~ l e a g u e s 'in
~ ~two distinct
neural cell lines. Since then, a wealth of in vitro evidence has accumulated to
Trk independent apoptosis
support an apoptotic role for ~ 7 5Ligand
~ ~ mediated
~ .
has been shown in a variety of neural cells that include sensory neurons135,136I
sympathetic neurons'37, motoneurons'388139 and hippocampal neurons140.~

7

expression is not limited to neurons; in fact oligodendrocytes and Schwann cells
also express ~

7 and5 have
~ been
~ shown
~
to undergo an NGF-dependent

~ 7 5 ~ ~ ~ - r n e d iaapt e
od
pt~sis'~'~'~~.

In vivo evidence for ~ 7 5 ~ ~ ~ - m e d i cell
a t edeath
d
has been found for two
different central nervous system (CNS) populations. Early retinal and basal
forebrain cells express ~ 7 5These
~ ~ cells
~ undergo
.
apoptosis, an effect that can
be blocked by NGF a n t i b ~ d i e s ' ~In~ .cholinergic neurons of the basal forebrain
there is a reduction in .the number of apoptotic cells in mice lacking the p75NTR
receptor'44. Further evidence suggesting that ~

7 independently
5
~
~regulates
~

cellular apoptosis comes from transgenic mice over-expressing the intracellular
domain of p75NTR,resulting in a significant reduction in numbers of syrr~pathetic
and sensory neurons as well as cell loss in the n e o ~ o r t e x ' ~
The
~ . deficit in the

peripheral nerves of these mice is primarily restricted to ur~myelinatedaxons
indicating that cell death was confined to those sensory neurons that are
normally receptive to NGF and which express TrkA. Cell death occurred in
neocortical cells, which do not express TrkA. This argues against a dominant
7 intracellular
5
~ domain
~
~with TrkA

negative effect; whereby, pairing of the ~

might lead to cell death by blocking the formation of high affinity receptors for
NGF. These studies suggest that the ~

7 intracellular
5
~ domain
~
independent
~
of

Trk initiated the cell death process. Moreover, in ~

7 knockout
5
~ mice,
~ the ~

number of sympathetic neurons at two weeks of age was significantly higher than
wild-type mice, indicating that apoptosis was reducedq3'. ~

7 knockout
5
~mice~

were also reported to display reduced apoptosis, as detected by TUNEL, of
spinal cord neurons at E l 1.5, and retinal neurons at ~ 1 5 . 5 ' ~ ~ .
Isolation of Neurotrophin Receptor Interacting Factors.

In general, it seems that neurotrophins can only induce cell death
through ~

7 in 5
cells ~not expressing
~
~
their specific Trk receptors137,146 - BY

contrast, coactivation of ,the appropriate Trk receptors inhibits neurotrophininduced

p75NTR-mediated apoptosis,

as

demonstrated

with

cultured

oligodendrocytes and neuronsq36.A number of interactors and their possible
functions have been described for p75NTR,many of them as a result of yeast twohybrid screens. ~

7 interactors
5
~ involved
~
~in transducing cell death include a

wildly expressed zinc finger protein designated NRlF (neurotrophin yeceptorjnteracting

NRlF knockout mice showed reduced levels of apoptosis in

the retina, and this reduction was quantitatively similar to that seen in p75NTRnull

~

mice. These results suggest that NRlF is an essential component downstream of
NGF and ~

7 in the
5 cell~death~ pathway.
~
A protein designated NADE (p75-NTR-

associated cell death executer) associates with ~
-

7 after5 NGF~binding
~ but
~ not

after binding of BDNF, NT3 or ~ ~ 4 1 5 ' ~It 'too
. seems to be involved in p75-NTRmediated apoptosis.
Another zinc finger protein that has been identified as an intracellular
interactor of p75NTR,the Schwann cell factor-1 (SC-I), is involved in cell cycle
arrest14'. SC-1 translocates from the cytoplasm to the nucleus after NGF, but not
BDNF, stimulation of transfected COS cells. Nuclear expression of SC-1 led to
loss of BrdU incorporation indicating a reduction in the rate of proliferation. The
GTPase RhoA has been isolated as a ~
screenl5'. ~
~

7 interactor
5
~in a ~yeast~two-hybrid

7 constitutively
5
~ activates
~
~ RhoA, whereas neurotrophin binding to

7 blocks
5
this
~ activation.
~
~ The link to ~

7 and5 RhoA
~ seems
~
~to be

functionally relevant, as the modulation of neurite outgrowth in ~ 7 5 ~ ~ ~ - e x p r e s s i n g
neurons by neurotrophins mimics the results obtained following RhoA
inactivation. Using coimmunoprecipitation and phosphorylation assays, a p75NTRassociated kinase15', as well as ERKI and E R K ~ " ~were
,
shown to interact with
~ 7 5 The
~ functional
~ ~ . significance of these associations is not clear, though
~

7 is 5
serine~ phosphorylated
~
~
in the intracellular domain. Association of

TRAF6 with ~

7 after
5 ligand
~ binding
~
~ leads to the activation of N F - K B ' ~ ~ .

Another report suggests that all members of the TRAF family interact with
~ 7 5 ~A ~
further
~ ' recently
~ ~ . identified interactor of p75NTR,designated NRAGE
(neurotrophin receptor-interacting MAGE), or MAGE-Dl, mediates NGF-

dependent apoptosis in sympa,thetic neuron precursor cells155. NRAGE also
causes cell cycle arrest when over-expressed in cultured cells, suggesting that
~

7 might
5 play
~ a ~
role in~ growth control throl~ghinteractions with NRAGE.

Interestingly, NRAGE disrupts the interaction between ~
functional interactions between NRAGE and ~

~~ ' . ~
7 and5~ r k~ ~ 'The

7 are5discussed
~
~ in greater
~

detail below.
There remain many pertinent issues to address before a coherent view on
naturally occurring neuronal cell death can be formed. However, evidences from
transgenic and cell culture studies have delineated a picture in which a dual
wave of apoptosis occurs. Early neural death of proliferating progenitors and
young neuroblasts is assuming a more detailed contour, and an in depth analysis
of the spatial, temporal and molecular links of proliferation, differentiation or
apoptosis will surely be informative to better clarify the physiological role of this
phenomena. Recently members of the bone morphogenetic family have been
found as prominent regulators holding key roles during neural development
including the regulation of neuronal and astrocytic determination and apoptosis in
the cortex 7-10 and instructive cell fate decisions in the neural crest 11-15.

Early Corticoqenesis.

Regionalization of the neural plate and early tube is controlled by secreted
molecules produced by a grid of patterning centers156-159 . Longitudinal pattering
centers are present along the ventral (axial mesoderm, and later the floor plate)
and dorsal (epidermal-neuroectodermal limits and latter the roof plate) aspects of

neural plate and early neural tube. Transverse patterning centers are present at
specific anterior posterior locations such as the rostral end of the neural plate
(anterior neural ridge, A N R ) ' ~ ~ ~and
' ~ ' at the midbrain-hindbrain boundary
( i ~ t h r n u s ) ' ~Each
~ . patterning center produces a distinct set of signals. Ventral
centers produce sonic hedgehog (shh) and B M P S ' ~ ~ -dorsal
' ~ ~ ; centers produce
BMPs and ~ n t s ' and
~ ~ transverse
* ~ ~ ~ patterning centers produce fibroblast
~ ~ the
' ~neuroepithelium
~ ~ ~ ~ ~ adjacent
.
to
growth factor (FGF) and ~ n t s ' ~ Thus,
transverse and longitudinal patterning centers are exposed to a corr~binationof
signals. While some insights into the combinatorial effects of extracellular signals
on cellular fate of neuroepithelial progenitors has been made, little is known how
combinations of these signals regulate cell

proliferation, survival and

differentiation in the CNS. Furthermore, less is known how these patterning
centers are established and how they affect each other.
Soon after folding of the neural plate into the neural tube, two pairs of
large vesicles evaginate from its walls. First, the optic vesicles grow from a
region near its rostral end, and give rise to the neural retina, pigment epithelium
and optic stalks. Then, the telencephalic vesicles grow from the rostrodorsal part
of the prosencephalon, and give rise primarily to the cerebral cortex and basal
ganglia17'. Neural and non-neural tissues produce a number of signaling
molecules including BMPs, shh and FGF8 within and adjacent to the
p r o s e n ~ e p h a l o n ' ~The
~ ~ 'expression
~ ~ ~ ~ ~ . of most BMPs is restricted to the dorsal
prosencephalon, while shh expression is largely ventrally restricted and FGF8
expression is primarily in the rostrum of the A I V R ' ~ ~Within
~ ' ~ ~ the
. forebrain

BMPs repress FGF expression, and shh maintains FGF e x p r e s ~ i o n The
~~~~~~~.
positional cue generated as a result of the combinatorial actions of these factors
regulates the expression of regional specific transcription factors, which have
direct effects on proliferation, survival, specification and morphogenesis.
Neuronal differentiation is promoted by both platelet-derived growth factor
(PDGF) and by NT-3. The cytokines leukemia inhibitory factor (LIF) and ciliary
neurotrophic factor (CNTF) are potent inducers of astrocyte production, and
thyroid hormone induces oligodendrocyte d i f f e r e n t i a t i ~ n ' ~ ~0,ther
- l ~ ~ . factors,
such as BlWPs can enhance both neuronal and astrocyte differentiation,
depending on the age of the stimulated cortical progenitors180,181

Signal Transduction of Bone Morphoqenetic Proteins
Bone morphogenetic proteins (BMPs) are members of the TGF-P
superfamily of secreted signaling m o ~ e c u l e s with
~ ~ ~ the
~ ' ~exception
~
of the
metalloprotease BMPI. There are more than 20 members known that can be
subgrouped according to the homology in their ~ e q u e n c e l ~ * -BMPs
' ~ ~ . are highly
conserved across the animal kingdom having been shown to participate in
numerous developmental events. For example, they influence gastrulation,
osteogenesis, neurogenesis, hematopoiesis and a p ~ ~ t o s i s ' ~ Despite
~ - ~ ~ ' . the
numerous extracellular ligands, only three Type-l and three Type-ll receptors are
known to mediate the s i g n a ~ s ' ~Following
~ - ~ ~ ~ .ligand binding to at least one TypeI and one Type-ll receptor, the Type-ll receptor phosphorylates the Type-l
receptor on specific serinelthreonine residues204s205.
The wide diversity of

biological effects appear to be partly due to intracellular cofactors that participate
in BMP signal transduction, as well as cross talk between BMPs and other
signaling pathways. Following phosphorylation of BMPR-I the R-Smads are
phosphorylated and released from the receptor and recruit the common mediator
Smad (Co-Smad, Smad4) into the signaling complex that is transported into the
nucleus and activates the transcription of specific target gene206-212.
In addition to
Smad signaling, BMPs have recently been shown to lead to the activation of p38
through additional receptor adapter proteins TAKI/TABI~'~-~~~.Furthermore,
there is data showing the activation of the RAS pathway and ERK kinase
pathway due to BMP s t i m u ~ a t i o n ~ ' ~ - * ~ ~ .
Bone Morphogenetic Proteins.
All BMPs are secreted as precursor proteins with an N-terminal
hydrophobic stretch of about 50-100 amino acids. The pro-BNIP is proteolytically
cleaved and the mature and active form is derived from the carboxylterminal
r e g i ~ n ' ~ ~A' hallmark
~~'.
of all BMPs is the presence of a cystein knot composed
of six cysteins followed by an additional cystein required for dimerization with a
second monome1222-224.
BMP Receptors.
Binding of the BMP to at least one Type-l and one Type-ll receptor
is necessary for activation of the BMP

TO date three Type-l

receptors have been identified [Alk2, Alk3 (BNIPR-la), Alk6 (BMPR-lb)] and three
Type-ll receptors [BMPR-II, ActRll and ~

c

t

~

l

l

~Generally,
] ~ the
~

Type-l receptors are the high-affinity binding receptors, whereas the Type-ll

~

~

~

receptors bind the BMPs alone with low affini@00s2271228.
Interestingly, the Type-ll
receptors are constitutively active serinelthreonine kinase receptors. The Type-ll
receptor phosphorylates the Type-l receptor at a conserved GS-Box, a
juxtamembrane domain enriched in glycines and serines205,229
The affinity for BMPs is dependent on specific Type-l and Type-ll
receptors200s201,
supporting the concept that receptor affinity is important for the
activation of specific signal transduction

The diversity of

signaling is also a consequence of differential receptor expression and
downstream signaling molecules that contribute to the plethora of signaling
responses.
Recently, BMPR-la, BMPR-lb and BMPR-II have been shown to exist as
either a preformed hetero-oligomeric complex or a homo-oligomeric complex on
the cell surface232.Moreover, the oligomerization mode of the receptors at the
cell surface determines the activation of downstream signaling. Should BMP bind
to the high-affinity receptor BMPR-la or BMPR-lb and then recruit BMPR-II into a
hetero-oligomeric complex leads to activation of p38. The other alternative is for
BMP to bind simultaneously to the preformed hetero-oligomeric complex
activating Smad signaling
The Smad Family and the "Canonical" Signaling Pathway.
There are three classes of Smad proteins: the receptor-activated
Smads (R-Smads), the common-mediator Smads (Co-Smads) and the inhibitory
Smads (I-Smads). Structurally, R-Smads (Smadl, Smad5 and Smad8) and the
Co-Smad (Smad4) are similar in that they share two highly conserved regions,

an N-terminal MHI domain (Mad Homology 1) and a C-terminal MH2 domain
separated by a less conserved linker region. However, Smad4 does not contain
the C-terminal SSXS phosphorylation motif present in R-Smads, and thus not
phosphorylated by the receptor195s234.
The MHI domain of the Smad4 and all RSmads, except for Smad2, can bind to specific DNA sequences, whereas the
MH2 domain mediates protein-protein interactions with Smads promoting homoor

hetero-oligomers and

additional transcriptional

co-activators or

co-

repressors235-238. Both R-Smads and Smad4 activate transcription primarily
through their MH2 domain239.This activity results, at least in part, from the ability
of the MH2 domain to recruit the general transcriptional co-activators p300 and
~ ~ ~ 2 4 0 - 2 4 4

. Both p300 and CBP have histone acetylase activity, enabling them to

increase transcription of target genes by loosening of the chromatin structure.
While Smads alone can bind to specific DNA sequences, their affinity is
considered to be too weak to serve as effective and highly specific DNA binding
proteins in

Thus, additional and numerous DNA binding partners are

required for efficient DNA binding and transcriptional regulation of target genes.
TAKIITABI and the "Non-Canonical" Signaling Pathway.
Additional studies suggest that a mitogen-activated protein kinase
(MAPK) pathway additionally mediates BMP signal transduction. These studies
have shown that BMP signals can be transduced by TGF-P activated kinase
(TAKA), a MAP kinase kinase kinase (MAPKKK), and TAKI binding protein 1
( T A B I ) ~ ~ ~When
~ ~ ~ ~TAKI
.
alone is over-expressed in Xenopus, it induces
apoptosis and this function is significantly inhibited when a kinase dead mutant is

used. However, co-injection of TAKI together with XIAP, which belongs to the
family of inhibitors of apoptosis (IAP), reduces TAKI mediated apoptosis, but
enhances ventralization of the embryo, thus mimicking BMP over-expression
phenotypes245.TAB1 activates TAKI by directly binding to its catalytic domain,
and over-expression of TAB1 enhances the ventralizing activity of TAKI when
co-injected. It should be noted that, in addition to BMPs other ligands such as
TGF-P, interleukin-I, and tumor necrosis factor (TNF)-a have been reported to
activate TAKI in certain contexts213p214,2469247,
and that TAKI has been implicated
in the activation of ,INK and p38 MAPK signaling pathways215,216,247-249
Neural p38 MAPK Signaling.
In both neural and non-neural cells the MAP kinase cascades are
among such evolutionarily conserved signaling pathways that strictly control cell
function and fate250-252 . Three MAP kinase cascades that converge on ERKs,
JhIKs and p38 MAPKs have been extensively characterized, and each consist of
three classes of serinelthreonine kinases, MAPK, MAPK kinase (MAPKK, also
referred to as MEK) and MAPKK kinase (MAPKKK). MAPKKK phosphorylates
and thereby activates MAPKK, and activated MAPKK in turn phosphorylates
MAPK. Whereas the ERK cascade is primarily involved in ,the control of cell
proliferation and differentiation by mitogens and growth factors, the ,INK and p38
cascades are preferentially activated by environmental stresses such as UV
radiation, X-rays, heat and osmotic shock, and by proinflammatory cytokines
such as TNF-a and I L - I ~ ~ ~ .

Recently, potential roles for JNKs and p38 MAPKs in neural apoptosis
have received a great deal of attention. In particular mice lacking JhIKs display
particular dysregulation of neural a p o p t o s i ~ ~ However,
~ ~ , ~ ~ ~several
.
lines of
evidences have suggested that p38 MAPKs also play roles in neural
a p o p t o s i ~ ~However,
~ ~ - ~ ~ ~these
.
studies are primarily based upon the use of
dorr~inantnegative or pharmacological inhibitors (SB203580) of p38, and thus it
remains unclear whether p38 pathway is involved in neural apoptosis in vivo.
Indeed, attempts to address abnormalities in neural development in mice lacking
the p38a gene have met with little success as embryonic lethality results during
early to mid gestation from deficits in angiogenesis260-263.
In this regard, analysis
of conditional knockout mice and knockouts for other p38 isoforms will be needed
to research a precise conclusion concerning a pro-apoptotic role of p38 MAPKs.
In addition to the regulation of cell death and survival as stress-activated
kinases, p38 MAPKs have been shown to possess diverse biological functions
including cell fate specification and control of cellular function, including neural
~ e l l s ~Much
~ ~ of
- ~
the~ current
~ .
data concerning p38 signaling in neural cell fate
decision as been garnered using the rat pheochromocytoma cell line PC12.
Recent studies have suggested that in addition to ERK mediated pathways, p38
signaling also

participates in the

nerve growth factor

(NGF)-induced

d i f f e r e n t i a t i ~ nBMP2
~ ~ ~ . also induces neural differentiation of PC12 cells268,269. in
this process, p38 MAPKs but not ERKs are activated upon BMP treatment.
Consistent with this, SB203580 and dominant negative MKK3 or MKK6
effectively inhibit BMP-induced differentiati~n~~'.
Thus, p38 pathway may play a

common role as a down stream target for both NGF and BMP mediated
differentiation. Nevertheless, it has not been fully determined how the activity of
p38 MAPK is regulated in neural differentiation, especially at the level of
MAPKKK.
The p38 pathway appears to activate MEF2 transcription factors in
response to calcium influx into cerebellar granule cells, and activated MEF2
regulates neural survival by stimulating MEF2 dependent gene transcription.
Since MEF2 is primarily expressed in differentiating neurons but not in actively
dividing neural progenitors it may act in newly formed neurons to support neural
activity dependent m a t ~ r a t i o n ~ However,
~'.
concerns over p38 signaling have
suggested a pro-apoptotic role for p38 in neural ~ e l l s ~ Plausible
~ ~ - ~ ~ ~ .
explanations for this apparent discrepancy are that the developmental state and
thus the physiological level of neural activity might control p38 pathway activation
or the way in which cells respond to p38 activity might changes at neurogenesis
progresses.

NRAGE and the MAGE Family of Proteins.
The human gene MAGE-A1 was identified by gene transfection approach
involving the stimulation of cytotoxic T-lymphocytes directed against a melanoma
cell line272.By hybridization of cosmids with a MAGE-A1 probe, 11 closely related
genes were

Together, these 12 genes form the MAGE-A cluster,

located in the q28 region of the X chromosome274.A sequencing effort directed at
the Xp21 region led to the identification of the MAGE-B cluster, which is

comprised of four genes275-277.
MAGE-C, a third group, comprises two genes
located in ~ q 2 6 - ~ They
7 ~ ~were
~ . identified following the analysis of cDNA
libraries enriched for tumour and testis-specific sequences by representational
difference analysis. These MAGE-A, -B and -C genes are not expressed in
normal tissues, except in male germ-line cells, and, for some of these genes, in
placental279.Seven MAGE-A genes, two MAGE-B genes, and two MAGE-C
genes are expressed in a significant proportion of tumours of various histological
types. The activation of these genes appears to result from the demethylation of
their promoter region280.
Pold and colleagues281have identified a fourth family of MAGE proteins
termed MAGE-Dl located at Xpl I.The full length MAGE-Dl cDNA clone was
described elsewhere282and its exon-intron structure is completely different from
other MAGE genes. MAGE-Dl is expressed in a variety of normal tissues and
tumours, which are in stark contrast to the expression of other MAGE proteins278.
A notable exception to typical MAGE expression has been necdin. Necdin,
which is specifically expressed in differentiated neurons, was found as a retinoic
acid-inducible neural differentiated protein in the embryonal carcinoma cell line
~ 1 9The
~ necdin
~ ~ cDNA
.
encodes a 37Kda protein consisting of 325 amino acid
residues, and the rrlRNA was expressed in brain, but not in non-neural tissues284.
Further immunohistochemical studies showed that necdin is a nuclear protein
expressed in differentiated postmitotic neurons and believed to function as an
associated growth suppressor exclusively in postmitotic neurons that are
differentiated in an irreversible manner285z286. Necdin has been shown to bind

several Rb interacting proteins. These include adenovirus EIA, the SV40 large T
antigen, E2F1, and ~ 5 3 ~ Similar
~ ' ~to~Rb,
~ necdin
~ .
binds and represses E2F1
mediated t r a n ~ c r i p t i o nOver-expression
~~~.
of necdin in proliferating cells induces
growth arrest285.Unlike necdin, Rb is expressed in neuroepithelial stem cells and
at reduced levels in postmitotic neurons68r289.
While Rb is a key regulator of
neural progenitor cell terminal differentiation, it may be less important in
maintaining the differentiated state as p130 does. In contrast, necdin that is
exclusively expressed in postmitotic neurons may have a role in the maintenance
of neuronal differentiation. Thus, in neurons the existence of molecules such as
necdin that are able to complement RbIpl30 function appear to be important in
the maintenance of neuronal differentiation. However, it raises the question as
whether other necdin-like molecules exist in which they share a greater functional
similarity to Rb. Indeed, MAGE-Dl is 32% identical and 60% similarity over the
N-terminus of the protein to necdin. This high degree of structural homology
leads us to the investigation of functional similarity as well.
In an attempt to elucidate novel ~

7 interacting
5
~ proteins,
~
~Verdi and

co~leagues'~~
employed the yeast two-hybrid system to screen a rat neural crest
cDNA library. A ~

7 binding
5
partner
~
~ termed
~ NRAGE was identified. BLAST

search revealed sequence homologue to human MAGE-Dl. NRAGE was found
to bind ~

and
7 in vitro
5
~ in~ vivo,~ and NRAGE associates with the plasma

membrane when NGF is bound to ~ 7 5 NRAGE
~ ~ ~ blocks
.
the physical
association of p7!jNTR with TrkA, and, conversely, TrkA over-expression
eliminates NRAGE-mediated NGF-dependent apoptosis. Thus, indicating that

interactions between NRAGE and TrkA with p7sNTR are functionally and
physically exclusive. NRAGE over-expression facilitates cell cycle arrest and
permits NGF-dependent apoptosis within sympathetic neuron precursor cells.
Therefore, NRAGE contributes to a ~ 7 5 ~ ~ ~ - d e p e n cell
d e ndeath
t
and suggests
novel functions for MAGE family of proteins.
Since ~

7 is expressed
5
~ not
~ only~in neural tissues, but many non-neural

tissues as well, a description of the developmental expression of p75NTRinteracting proteins is hypothesized to reflect ~

7 receptor
5
~expression.
~
~ An

understanding of the developmental regulations of ~ 7 5 ~ ~ ~ - i n t e r a cproteins
t i n g is
important for the fundamental knowledge of when and where these proteins exert
a physiologically relevant effect in vivo. Indeed, recent work has characterized
~

7 independent
5
~ functions
~
~ for NRAGE mediated apoptosis. NRAGE has been

shown to facilitate an interleukin-3 withdrawal induced apoptosis through

~~.
additional studies suggest that NRAGE
competitive binding to X I A P ~ Moreover,
associates with members homeobox transcription factors Msx2 and DIx5 and
translocates to the nucleus291s292 and this interaction is redistributed to the
plasma membrane when the tyrosine receptor kinase

ROR2 is present293.

Collectively these results suggest that NRAGE may function in the BMP signaling
cascade regulating early neural progenitor apoptosis. In support of this the
capacity for NRAGE to promote apoptosis is significantly enhanced during active
proliferation of neural progenitors294.Therefore, it becomes pertinent to establish
the presence of NRAGE within the neural precursor pool during peek periods of

early progenitor apoptosis and determine whether the established BMP mediated
cell death in these cell is dependent on NRAGE.

CHAPTER 2
Expression Analysis of Novel p7sNTRSignaling Proteins that Regulate cell
Cycle-Progression and Apoptosis.
Abstract

Neurotrophin Receptor-interacting MAGE (NRAGE) is the most recently
identified ~

7 intracellular
5
~
~
binding
~ protein. Previously, NRAGE over-

expression was shown to mediate cell cycle arrest and facilitate Nerve Growth
Factor (NGF) dependent apoptosis of sympathetic neuroblasts in a p7!jNTR
specific manner. Here we have examined the temporal and spatial expression
patterns of NRAGE and three other ~ 7 5 ~ ~ ~ - i n t e r a cproteins
t i n g over the course
of murine embryogenesis to determine whether their expression is consistent
with its proposed functions. We demonstrate that IVRAGE mRNA and protein are
expressed throughout many embryonic and adult tissues. The mRNA is
constitutively expressed within each tissue across development. However,
expression of NRAGE protein displays a tight temporal tissue specific regulation.
During early CNS development, NRAGE protein is expressed throughout the
neural tube, but by later stages of neurogenesis, NRAGE protein is restricted
within the ventricular zone, subplate and cortical plate. Moreover, NRAGE protein
expression is limited to proliferative neural sub-populations as we fail to detect
NRAGE expression co-localized with matureldifferentiation associated neural
markers. Interestingly, f"lRAGE1sexpression is not restricted solely to areas of
~

7 expression
5
~ suggesting
~
~ that NRAGE may mediate proliferation and/or

apoptosis from other environmental signals in addition to NGF within the CNS.
The distribution of NADE, NRlF and SC-1 mRNAs during murine development
suggests that the action of these genes is in fact not limited to regions of
expression either. Specifically, a detailed comparison of the spatial and temporal
expression domains of NADE, NRlF and SC-1 during brain development
revealed regions of co-expression with

but also illustrates a distinct and

discordant spatial and temporal expression. These results yield novel insights
into the unique developmental characteristics of the ~ 7 5 ~ ~ ~ - i n t e r a cproteins,
ting
thus revealing their diverse signaling potential during embryonic development.
Specifically, our data supports previously characterized roles for NRAGE as a
mediator of precursor apoptosis and a repressor of cell cycle progression in
neural development.

Introduction

In the course of development, the generation of neurons and glia from
neural stem cells is regulated at steps that include lineage commitment,
progenitor proliferation, differentiation, cellular migration and programmed cell
death (apoptosis). Apoptosis is crucial for regulating not only the normal number
of terminally differentiated neurons and glia, but also the number of neural
progenitors16,295.
In the classic neurotrophic theory, post-mitotic neurons compete for limited
amounts of trophic factors, the neurotrophins, which mediate neural survival.
Neurotrophins include four distinct and structurally related homodimeric

compounds. Members of .this family include nerve growth factor (NGF), brainderived neurotrophic factor (BDNF), neurotrophin-3 (IVT3) and neurotrophin-415
( ~ ~ 4 1 5These
) ~ ~
molecules
~ ~ ~ act
~ ~on. neurons by binding to distinct classes of
membrane

receptor^^^. One class consists of p75 neurotrophin receptor

( ~ 7 5 ~ a~ member
~1,
of the tumour necrosis factor (TI\IF)/Fas/CD40 receptor
superfamily that binds all four neurotrophins with relatively low affinity298p299.
The
other class consists of Trk receptor tyrosine kinases, including TrkA, B and C and
their various isoforms. Binding of neurotrophins to Trks is specific, with NGF
binding to TrkA, BDNF to TrkB and NT-3 binding to TrkC and to a lesser extent
~ r k A ~ ~Individual
~ ' ' ~ . Trks are necessary and sufficient to confer a functional
response to their cognate ligands in the absence of ~ 7 5 ~ However,
~ ~ ~ "Trk
. and
are often co-expressed endogenously and in vitro data has shown that
increases the affinity of NGF binding ~ r k A ~and
"
enhances TrkA
autophosphorylation100,302
Despite the observations that Trk and ~

7 coordinate
5
~ neurotrophin~
~

dependent survival of neurons, evidence is mounting indicating that ~

7 can5

~

~

act independently of Trk as an inducer of cellular a p ~ ~ t o s iLigand
s ~ ~ ~mediated
.
~

7 dependent
5
~ apoptosis
~
~ has been demonstrated within several developing

neural lineages including sensory neurons135-136, sympathetic neuronsq3?,
motoneurons'38-139 and within non-neural lineages such as oligodendr~cytes~~'
and Schwann cells142.In vivo evidence also supports a role for ~
apoptosis. Endogenous NGF binding ~

7 in 5

~

7 induces
5
~
apoptosis
~
in
~ developing

chick retina neurons303.Further evidence suggesting that ~

7 independently
5
~
~

~

~

regulates cellular apoptosis comes from transgenic over-expression and
knockout studies. Mice over-expressing the intracellular domain of the ~

7

5

~

~

~

5

~

resulted in a dramatic increase in neural death in both the central and peripheral
nervous system14' and mice lacking genes for ngf andlor p7!jNTRhave reduced
cell death in the retina and in the mantle zone of the spinal cord143,304
In an attempt to identify down-stream modl~latorsof ~

7 signaling,
5
~

several groups have successfully utilized the yeast two-hybrid paradigm. Two
zinc finger proteins named Schwann Cell Factor-I (SC-1)14' and Neurotrophic
Receptor Interacting Factor ( N R I F ) ' ~have
~
been shown to interact with the
juxtamembrane region of ~ 7 5 A~ third
~ ~ protein,
.
Neurotrophin Receptor
Associated Cell Death Executor or N A D E ' ~associates
~
with the intracellular
~

7 death
5 domain.
~
~These
~~

7 interacting
5
~ proteins
~
functionally
~
have been

associated with either cell cycle regulation ( ~ c - 1 ) 'or~ ~NGF dependent
apoptosis (NADE and NRIF)147,148 . SC-1 over-expression in proliferating cells
induces cell cycle arrest by a currently unknown mechanism, although it may be
directly involved in the down regulation of c-myc expression. NRIF knockout mice
showed reduced levels of apoptosis in the retina, and this reduction was
quantitatively similar to that seen in ~

7 null5mice.~ NADE
~ also
~ is involved in

p75NTR-mediatedapoptosis by regulating the activation of caspase-3 upon NGFI
~

7 i n t e5r a ~ t~i o n s~l ~
We
~ . have
~
cloned and characterized an additional ~

7

interacting protein we termed NRAGE for Neurotrophin Receptor-interacting
MAGE h o m o ~ o g ' ~NRAGE,
~.
previously reported as IVAGEDI, is a member of
the MAGE gene family that have previously been shown to code for surface

antigens expressed by tumour cells but recently have been implicated on
regulating

cell

cycle

progression,

apoptosis

and

neurogenic

disorders1558278s2821305.306. NRAGE, like SC-1 and NRIF, associates with the
juxtamembrane region of ~

7 and5over-expression
~
~
~ mediates both cell cycle

arrest in proliferating cells, as well as a N G F - P dependent
~ ~ ~ ~ apoptosis
~
of
sympathetic neuroblasts. Therefore, NRAGE and other ~ 7 5 ~ ~ ~ - i n t e r a c t i n g
proteins may posses multiple functions in vivo as a growth arrest protein and as
a pro-apoptotic protein.
Until recently, MAGE gene expression was believed to be restricted
primarily to tumour cells with the exception of male germ cells and placental
cells279.However, one notable exception is the MAGE family member Necdin.
Necdin is expressed in virtually all postmitotic neurons and is believed to function
as a differentiation associated growth

suppress^?^^^*^^. Recently a sub-branch of

the MAGE family tree, consisting in part with MAGEDI (NRAGE), have been
reported to be expressed in a variety of normal as well as transformed
Therefore, since NRAGE or MAGEDI may possess multiple
cells155s278~282~305~306.
functions during embryogenesis, a detailed account of the spatial and temporal
regulation of NRAGE, NRIF, NADE and SC-1 expression is warranted in order to
decipher the functional significance of NRAGE expression during development.
Our results indicate that in general, the spatial and temporal expression of
NADE, NRIF and SC-1 co-localized with known ~

7 expression
5
~ in~ the ~

developing nervous system. However, specific gene expression patterns exist in
which these interacting proteins are expressed independent of ~

7 expression
5
~

~

~

and each other. Also, outside the nervous system, NADE, NRlF and SC-1 mRNA
expression, like that of NRAGE, was observed in a wide variety of tissues. The
tissue distribution of these genes suggested that their actions are not solely
limited to ~

7 expression
5
~ domains
~
~ and may indeed have functions in

regulating development independent of ~

7 signaling
5
~events.
~

~

Moreover, we report the developmental expression of NRAGE during
murine embryogenesis. Both the mRNA and protein are widely expressed.
NRAGE message is detectable early in embryonic development and is
expressed in all tissues examined into adulthood. However, the expression of
NRAGE protein is strongly temporally and spatially regulated in a tissue specific
manner. During cortical neurogenesis, NRAGE protein expression becomes
restricted to areas of active cellular proliferation and regions where trophic
dependent apoptosis predorr~inantlyoccurs. In the peripheral nervous system,
NRAGE protein levels fluctuate in concert with sympathetic neuroblasts exiting
the cell cycle and undergoing trophic factor mediated cell death. However, this
early phase of NRAGE expression is in the absence of any detectable NGF
receptors strongly suggesting that NRAGE functions are independent of ~

7

in mediated neuroblasts mitotic arrest or apoptosis. Taken together these results
demonstrate that NRAGE protein expression yields a complex spatial and
temporal regulation supporting a dual role as a growth arrest protein and a
mediator of ~

7 regulated
5
~apoptosis.
~
~

5

~

Materials and Methods
Embryo and Tissue Collection.
Time pregnant matings of CD1 mice were established at the Maine
Medical Research Center Institute breeding facility. The observation of the
vaginal plug was designated as embryonic day 0.5 (E0.5). Time pregnant
Sprague-Dawley Rats were purchased from the Charles River Company
(Montreal, QE, CANADA).
Pregnant mice were sacrificed on consecutive days (E7-E21). The
embryos were dissected from the uterus in RNAse free phosphate-buffered
saline pH 7.4 (PBS), washed in PBS and fixed in 4% paraformaldehyde (PFA) in
PBS. 10pm sections of parafin embedded tissues were generated using a
progressive instrumentation microtome (Fisher).
Murine tissues (ElO-adult), listed in table 1, were harvested, frozen in
liquid nitrogen and stored at -80°C until use. Embryonic brain was obtained by
dissecting directly caudle to the mandible and subsequently removing the skull
and meninges. Neural tubes (somites 1-4, 5-12, 13-caudle) with somites
removed but with adjacent sympathetic and dorsal root ganglia were maintained.

62 Sympathetic Neuroblasts Isolations.
Sympathetic ganglia's were dissected from embryonic Sprague Dawley
rats from E13-El8 of gestation. The sympathetic chains were isolated from
thoracolumbar regions and treated with a combination of lmglml elastase and
lmglml collagenase in minimal essential medium at 3 7 ' ~for 30 min. The cells

were stained with the B2 antibody and positive cells were isolated using
fluorescence activated cell sorting307.82' sympathetic precursors were plated in
a

serum-free

modification of

L15N2

medium as

described

in detail

elsewhere307,308
Northern Blotting.
Mouse and rat poly-A enriched multiple tissue Northern blots were
purchased from Clontech. A blot containing total RNA from normal human
tissues was purchased from Invitrogen. Both human and mouse blots were
probed with a 300 bp fragment of human NRAGE. This fragment was generated
by polymerase chain reaction (PCR) over a common sequence (forward primer,
5' TTT AGT AGT GGC ATT CTG GG 3'; reverse primer, 5' CCC AAC TGC CAA
TGA GAT GG 3'). The fragment was cloned and sequenced to verify its
authenticity. The rat blot was similarly probed, with a 400 base pair (bp) cDNA
containing the 5' U-TR of rat NRAGE. Probes were radiolabeled with 3 2 ~ - d ~ ' r ~
(Amersham) by random priming, and hybridizations were performed using the
ExpressHyb system (Clontech) according to manufacturers recommended
protocol.
In situ hybridization.
In situ hybridization of murine sections were performed according to the

method of ~ r o v e s ~ Negative
~'.
sense control (5' to 3' orientation) and NRAGEspecific antisense (3' to 5' orientation) digoxigenin-labeled riboprobes were
synthesized (Roche) from a linearized NRAGE subclone comprising a 400bp
fragment of the NRAGE 5' UTR. Mouse p75NTR,NRIF, NADE and SC-1

digoxigenin-labeled riboprobes corresponding to the published GenBank
sequence were also generated.
Briefly, slides were dewaxed in a series of three xylene washes, then
hydrated in a graded ethanol series (100%, 90%, 70%, 50%), washed twice in
RNAse free PBS and incubated for 20 minutes in 0.2 N HCI-DEPC H20.
Subsequently, slides were washed twice in 2X SSC for 5 minutes and then
incubated at 55OC in prehybridization buffer3'' for 120 minutes. At this point, the
prehybridization was replaced with fresh prehybridization buffer containing 1
pg1mL riboprobe and hybridization allowed to occur overnight at 55°C.
Following hybridization, slides were treated with 20 pg/mL RNAse A and
washed in a series increasing stringency for 10 minutes at 45°C as described
e~sewhere~~'.
After washing, sections were incubated at room temperature (RT)
in TBST and 10% goat serum (blocking buffer) for 1 hour at which point the
blocking solution was removed and fresh blocking buffer containing a 11200
dilution of anti-digoxigenin-Alkaline phosphatase Fab fragments (Roche) applied
overnight at 4OC. Following the incubation, slides were washed in a solution
containing 100mM Tris-pH 9.5, 50mM MgCI2, 100mM NaCI, 0.1% Tween-20 (AP
Buffer). Visualization of bound probe was performed by incubating slides in AP
buffer containing 75 mg/mL Nitro blue tetrazolium, 50 mg/mL 5-Bromo-4-Chloro3-lndoyl-Phosphate (Roche) and 5mM Levamisole (Sigma) for up to four hours.
Sections were washed extensively in PBS. NRAGE mRNA expression was
visualized on an Olympus 1x70 microscope using bright field illumination
(Olympus).

lmmunohistochemistry.
In this study, two affinity purified NRAGE specific polyclonal antibodies
were employed. Both a-NRAGE antibodies were generated from GST fusion
constructs encoding either the N-terminal 31-396 amino acids or amino acids 53295 of rat NRAGE'~'. These antibodies were designed to avoid cross-reactivity
with the Necdin and MAGE homology domains of NRAGE. Unless stated, all
immunohistochemical procedures occurred at RT for 1 hour.
Slides were dewaxed in a series of three xylene washes for 5 minutes
each. Then hydrated in a graded ethanol series [loo%, 90%, 70% including 1%
Sudan black B to prevent tissue autofluorescence (Sigma), 50%] and washed in
PBS. Sections were incubated for I hour at RT in blocking buffer (10% goat
serum in PBS) prior to the addition of NRAGE specific antibodies (11100 dilution
in fresh blocking buffer). Sections were then thoroughly washed in PBS before
the appropriate secondary antibodies (11200 dilution, Chemicon) were applied.
Sections were then washed in PBS for 10 minutes and incubated for an
additional 10 minutes in PBS containing 1 pglmL Hoechst 33258 (Sigma).
Sections were again thoroughly washed in PBS and staining visualized on an
Olympus 1X70 fluorescent microscope.
For the cellular determination of NRAGE expression, adherent cortical
cultures were fixed in 4% paraformaldehyde in PBS (10 minutes), rinsed in PBS
and co-labeled with the a-NRAGE polyclonal antibodies and monoclonal
antibodies against either the neural markers, neurofilament48 (NF-68),
neurofilament-200 (NF-200) and MAP2aIb or the glial specific marker, glial

fibrillary acidic protein (GFAP) (Sigma). Appropriate species and isotype specific
secondary antibodies conjugated to FlTC or Rhodarr~inewere used as secondary
detection reagents together with Hoechst 33258 (1 pglml).
Semi-quantitative RT-PCR.

Total RNA was isolated with Trizol (Invitrogen) as per manufacturer's
specifications. Total RNA was treated with DNAse 1 (78 U1p.L) (Invitrogen) to
eliminate any potential genomic contamination and reprecipitated. cDNA was
synthesized from 5 pg total RNA with Superscript II (Invitrogen) using an Oligo
(dT)12-18primer according to previously published

procedure^'^^. Jack slowly

began thrusting and they rocked together in synchronous rhythm with the camel's
gait. lrina dipped her tongue in and out of his mouth as she stroked and explored.
They moaned at first in frustration at not being able to touch each other
completely, but as they pounded together faster, they concentrated instead on
the sensation of their physical connection.
All PCR reactions were performed in the linear range of amplification as
determined empirically for each cDNA sample generated. An 800 bp cDNA
fragment was amplified using specific primers for NRAGE that lie outside the
MAGE domain. A 300 bp p-actin fragment was also amplified as a positive
control and used for semi-quantitative purposes. For NRAGE the forward primer
sequence was 5'-CTG CCA ATG AGA AGG CTG ATA CTG-3' and the reverse
primer sequence was 5'-AAG CTG ATG GTG TCT GCC TAG CTG-3'. The

P-

actin forward sequence was 5'- TGT TAC CAA CTG GGA CGA CA -3' and the
reverse primer sequence was 5'- CTC TCA GCT GTG GTG GTG AA -3'. The

p75 forward sequence was 5'- CAA CCA GAC CGT GTG TGA AC -3' and the
reverse primer sequence was 5'- TGG CTA TGA GGT CTC GCT CT -3'. The
NRlF forward sequence was 5'- GTG ATG CTA GAG ACC TTG GG -3' and the
reverse primer sequence was 5'- CAC CAT GGC ATC GCT ACT GTC C -3'. The
NADE forward sequence was 5'- CAT TCC CAA CAG GCA GAT G -3' and the
reverse primer sequence was 5'- GGC ATA AGG CAG AAT TCA TC -3'. The
SC-1 forward sequence was 5'- TGG CCA CGA AGT AGC ATT GG -3' and the
reverse primer sequence was 5'- TTG ACC CGG TTT GCA ATG TG -3'. Primer
sets cross an intron-exon boarder facilitating the detection of any potential
genomic contamination in our samples. Arr~plificationof cDNA was performed
between 25-30 cycles (25 cycles for actin) [denature: 94OC, 30 seconds; anneal:
56OC, 30 seconds; extension 72OC, 4.0 seconds] using 1/20th of the generated
cDNA. PCR products were. separated on a 1% agarose gel and visualized with
e'thidium bromide. Resulting amplification products were analyzed using a Kodak
Electrophoresis Documentation and Analysis System 120 unit. The ratio of the
net intensity of actin amplification to the net intensity of the NRAGE amplification
product resulted in the relative NRAGE rrlRlVA expression level.
Western Blotting.

Western blots were prepared using adult and fetal CD1 mouse tissues
collected from E l 0 through E21 solublized in Trizol (Invitrogen) and protein was
obtained by exhaustive dialysis of the phenol-ethanol supernatant against 0.1%
SDS, quantitated using the BCA assay310,and fractionated by 8% SDS PAGE
under reducing conditions. After semi-dry transfer onto Immobilon-P (IWillipore),

membranes were probed with either polyclonal rabbit a-NRAGE antibodies. Blots
were developed using horseradish peroxidase conjugated-goat anti-rabbit IgG
(Jackson lmmuno Research Laboratories Inc.) and a chemiluminescent reagent
(New England Nuclear), and exposed to Fujifilm.
Mouse Brain Cortical Cultures.

Timed pregnant mice were sacrificed at E l 3 and the embryos were
aseptically removed and placed in Hank's balanced salt solution (HBSS)
(Invitrogen) supplemented with 10% fetal bovine serum (FBS). Cerebral cortex
was removed, freed of meninges, dispersed with 0.05% trypsin-EDTA and
filtered with 70 pm nylon cell strainers (VWR). Cells were seeded (2x10~
cellslmL) on poly-D-lysine coated 60 mm dishes in a medium containing 38%
Neurobasal

medium,

60%

DMEMlF12,

2%

FBS,

and

0.4

pllmL

penicillinlstreptomycin (Invitrogen). Once adherent (within a few hours), the cells
were allow to differentiate for 5 days in serum free media comprised of 40%
Neurobasal medium, 60% DMEMIF12, and N2 supplements (0.6% D-glucose, 10
mg1L insulin, 20 mglL transferrin, 61 yM putrescine-HCI, 20 nM progesterone and
30 nM sodium se~enite)~".Cortical astrocyte cultures were generated from E l 3
mouse brain by seeding cortical progenitors as above and differentiating the
adherent cells in DMEM, high glucose, L-glutamine, 10% FBS and 0.4 pllmL PS
for two weeks.

RESULTS
NADE, NRIF, and SC-1 mRNAs are Extensively Expressed in Adult Mouse
Tissue.
To investigate the tissue distribution of p75NTR,NADE, NRlF and SC-1
mRNAs, RT-PCR analysis was performed on total RNA isolated from selected
adult mouse tissues (Fig. 1). NADE mRNA expression was ubiquitous in all
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Figure 1. ~ 7 5 ~ ~ ~ - l n t e r a cProtein
t i n g mRNAs are Widely Expressed in Adult
Tissues.
Adult mouse tissues were assessed for ~

7 and5 ~ 7 5~~ ~ ~~- i n t e~r a c t o r

mRNA expression. Reverse transcription-polymerase chain reaction products
were stained with ethidium bromide on 1% agarose gels. ~

7 mRNA
5
~

expression was detected in most adult tissues assessed. NADE was detected in

~

~

all tissues assessed while NRlF and SC-1 were found predominantly in ~

7

5

~

5

~

expressive tissues.

tissues assessed. In general, ~

7 interacting
5
~ proteins
~
~were spatially and

temporally co-expressed with p75NTR,however the correlation was not absolute.
For example, all three ~
even though no ~

7 effector
5
transcripts
~
~
were
~
expressed in the heart

7 message
5
~ was~ identified
~
(even after-45 cycles of

amplification). Conversely, NRlF and SC-1 transcripts were not expressed in the
thymus, where ~

7 message
5
~levels~were~observed. Each of the effectors also

showed unique tissue distributions. SC-1 message was not observed in the lung
where NRlF and WADE mRlVAs were identified. Furthermore, NADE mRNA was
identified in gallbladder and adrenal gland, where neither p75NTR,NRlF or SC-1
were expressed. Collectively these results demonstrate the wide spread
expression of ~ 7 5 ~ ~ ~ - e f f eproteins
c t o r predominantly in concurrent expression
with p75NTR,although there were specific differences between p75NTR
and ~

7

-effectors expression patterns implicating that p7sNTReffector proteins have a
broader and non- ~

7 based
5 role
~ in signaling
~
~ events during development.

NADE, NRlF and SC-1 mRNAs Display Distinct Temporal Regulation.
Since all three p75NTReffectors1mRNAs were expressed within the brain,
we chose to characterize their temporal expression throughout neurogenesis.
Semi-quantitative RT-PCR analysis was performed on total RNA isolated from

ElO-adult mouse brain to assess changes in mRNA levels across development
(Fig. 2).
Cortical Gene Expession of p75NTR
Interactors Across Development

tp75NTR
-)NADE
-A-NRIF
*sc-1

i

El0

El2

El4

El8
Developmental Age

El6

E20

PI

Adult

Figure 2. Transcripts for ~75*~~-lnteracting
Proteins Show Discrete
Temporal Expression Patterns During Brain Development.

Semi-quantitative RT-PCR analysis of ~ 7 5 ~ ~ ~ - i n t e r aprotein
c t o r mRNAs
during mouse brain development (n=4 performed in triplicate). Expression levels
are equilibrated to E l 0 p-actin levels for each age and expressed as a ratio of
the E l 0 ~

7 interactorlactin
5
~
~ levels.
~ A ratio of 1 reflects no change in the

message level compared to E l 0 levels.

All three ~ 7 5 ~ ~ ~ - e f f emRNA
c t o r species were expressed with specific temporal
trends reflecting changes in mRNA levels across development. Consistent with
published reports, ~

7 mRNA
5 levels
~
~increase
~ as neurogenesis progresses

and starts to decline concurrent with the peak time of programmed cell death at
E18, before leveling off to adult levels by birth (Buck et al., 1987). Whereas,
NRlF gene expression gradually decreased as development progressed, SC-I
message levels increased 5-fold over the same developmental window and
NADE mRNA levels remained invariant across development.
To localize ~

7 interacting
5
~ protein
~ gene
~ expression to specific cellular

regions within the brain, in situ hybridization was done on mouse serial sections
of the developing brain (E7.5-PI). Sense riboprobes were used as controls with
no staining detected (Fig. 3F, L, R). At E7.5, NADE and NRlF mRNA was
detected in the egg cylinder, amnion, chorion, syncytiotrophoblast and uterine
tissue (data not shown). Whereas, SC-1 mRNA was detected only in the embryo
and syncytiotrophoblast at E7.5 (data not shown). By E l I , the single proliferative
neuroepithelial layer of the forebrain, midbrain and hindbrain all showed NADE,
NRIF and SC-1 mRNA expression (Fig. 3A, G, M). Similar results were found for
p75NTRdistribution at this age (Fig. 3s). In the mouse, expansion of the cortex
begins at approximately E l 3 with generation of the subplate. By E l 5 distinct
cortical laminae include the marginal zone, cortical plate, subplate, intermediate
zone, subventricular and ventricular zone. The cortical plate and subplate zones
are transient structures with p7CiNTRexpression specific to the s u b p ~ a t e ~ ' * -In
~'~.
the E l 5 mouse, NADE, NRlF and SC-1 were identified most prominently in the
subplate regions of the cortex (data not shown). Moreover, expression was
observed in the subplate and cortical plate laminae from E l 6 through P I for

NADE, NRlF and SC-1 (Fig. 3B, C, H, I, N, 0 ) . ~

7 mRNA
5 was
~ identified
~
~

within the cortical plate and subplate zone during mid-neurogenesis (Fig. 3T).

NADE

NRlF

SC-1

p75NTR

Ell
Cortex

E l6
Cortex
..

El5
Cortex
Control

Figure 3. NADE, NRIF and SC-1 Expression Coincided with p75NTR

Expression Areas in the Developing Cortex and Neural Tube.

Shown are in situ hybridizations for NADE, NRIF, SC-1 and ~

7 mRNA
5

using serial sections of mouse embryonic tissue. Black staining and arrows
denote positive gene expression. Panels (A, G , M, S): E l 1 cortex, (B,H, N, T):
16 cortex, (C, I, 0,U): P I cortex, (D, J, P, V): E l 5 thoracic spinal cord, (E, K, Q,

W): E l 4 DRGs, (F, L, R) E l 5 control cortex. LEGEND: CP: cortical plate, MT:
mantle zone, SP: subplate, VZ: ventricular zone. Scale bar for (A, F, G , L, M, Q-

S) = 100 pm. Scale bar for (B-E, H-K, N-P, T-V) = 100 p.m.

However, unlike NADE, NRlF and SC-1 by late neurogenesis receptor
expression was predominantly restricted to the subplate cells (Fig. 3U).
The neuroepithelial wall of the diencephalon, mesencephalon and
mylenecephalon are formed from proliferative cells of the ventricular zone that
migrate out into the subventricular region. NADE, NRlF and SC-1 mRNA were
identified within the developing subventricular zones (data not shown).
Since ~

7 is highly
5
~expressed
~
~in the neural tube, surrounding dorsal

root ganglia and sympathetic ganglia, we assessed gene expression within these
regions. NADE, NRlF and SC-1 were all expressed in the mantle zone of the
developing spinal cord (Fig. 3D, J, P), as was ~

7 (Fig.
5 3V).
~ Also,
~ gene
~

expression of all three ~ 7 5 ~ ~ ~ - i n t e r a cwas
t o r spresent in the dorsal root and
sympathetic ganglia (Fig. 3E, K, Q, W).

~

~

~

Overall, NRlF mRNA expression phenocopies the mRNA expression of
p75NTR,supporting its role as a bona fide ~

7 effector
5
~protein.
~ Likewise,
~

NADE mRNA was spatially expressed in a similar manner to ~ 7 5The
~ mRNA
~ ~ .
expression of SC-1 coincides both spatially and temporally with that of ~

7

mRNA. -The increase in Schwann cell factor-I mRNA over time may reflect its
role in mediating the ~

7 induced
5
~growth
~ arrest
~
in later development,

presumably during glial development.

NRAGE mRNA is Widely Expressed Throughout Development.

The ~

7 has 5been ~implicated
~
in
~ mediating apoptosis both in vitro and in

vivo. The demonstration that three ~

neurotrophin induced apoptosis in a ~
lends credence to the hypothesis that ~

7 interacting
5
~ proteins
~
~ facilitate
7 dependent
5
~ manner
~
~
in vitro further
7 is a5 pro-apoptotic
~
~ receptor.
~
We

wished to determine whether one such mediator of ~

7 signaling,
5
~ NRAGE,
~
~

was expressed in temporal and spatial accordance to mediate such a function.
To determine NRAGE gene expression across development, a mouse
developmental Northern blot was probed for NRAGE using a 300 bp segment of
the 5' UTR of NRAGE to avoid the MAGE homology domain, thus insuring our
results would not be confounded with other MAGE family members. A single
2.9kb band, representing the full length mRNA was detected at the earliest time
point represented (E7) and at all subsequent ages examined (Fig. 4A)
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Figure 4. NRAGE mRNA is Expressed Through Development and Identified
i n a Variety of Murine and Human Tissues.
(A) Northern analysis of a developmental time course of NRAGE. NRAGE

expression is detected at E7 through E17. (B) Northern analysis of adult rat
tissue expression for NRAGE. (C) Northern analysis of adult human tissue
expression for NRAGE.

Examination of NRAGE mRNA expression at earlier embryonic ages by RT-PCR
revealed expression at all ages tested (€3-E6) and in murine embryonic stem
cells (data not shown). The presence of NRAGE gene expression at stages of
development prior to the onset of neurogenesis or germ layer specification

indicates a possible role for NRAGE other than mediating ~

7 Ineurotrophin5
~
~

~

induced apoptosis.
In general, MAGE family members are expressed only in tumour cells with
the one major exception being the neuron specific MAGE member Necdin and

the recently described M A G E D ~ ~ We
~ ~then
~ addressed
~ ~ ~ ~ whether
~ ~ ~ , ~ ~ ~ .
NRAGE, like Necdin, was predominately expressed in the nervous system or
was more similar to the ubiquitous expression of M A G E D I ~ ~Probing
~.
of an adult
rat tissue and human tissue Northern blot using the NRAGE specific probe,
revealed that unlike Necdin and most other MAGE genes, NRAGE mRNA
expression was detected in most tissues. An expression profile that was more
similar to M A G E D ~ ~(Fig.
' 4B, C). In the rat, the highest levels of expression were
detected in the brain and liver with lower levels found in the remaining tissues
examined. NRAGE expression pattern in human tissues was also wide spread.
NRAGE mRNA was once again most prevalent in the brain, but in contrast to the
tissue distribution of NRAGE mRNA in the adult rat, high levels of transcripts
were also expressed in the lung and kidney with little expression in the liver.
Moreover, NRAGE was detected in both skeletal muscle and spleen in adult
human tissues, two tissues in rat where the levels of NRAGE mRNA were just
above the threshold of detection. These differences in expression patterns and
levels may reflect either differing physiological functions or tissue regulation of
NRAGE between species. The significance of the expansive tissue distribution
demonstrates the unique and atypical expression pattern of MAGEDI subfamily
members. The diverse nature of NRAGE's tissues distribution indicates potential

physiological relevance throughout development and into adulthood and may not
be limited to signaling events transduced through the ~ 7 5 ~ ~ ~ .
The

pleiotropic

nature of

NRAGE's

physiological functions

was

hypothesized to be demonstrated through its gene expression distribution. Since,
the highest levels of NRAGE expression were detected in rat and human brain,
we asked whether this reflected a generally higher expression level of NRAGE
mRNA throughout the entire brain or whether a subset of specific brain regions
express varying amounts of transcripts. In addition, because each specific brain
region develops at different time points during gestation, we were interested
whether individual structures express NRAGE mRNA at varying levels based on
their respective stages of development. To this end, we sectioned mouse
embryos from E7 through adulthood and performed in situ hybridization using an
NRAGE and ~

7 specific
5 riboprobe.
~
~ We
~ employed riboprobes to increase our

sensitivity and AIRAGE specificity. Negative control (sense) riboprobes revealed
no staining (Fig. 5F, L, P).

NRAGE
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Figure 5. NRAGE is Expressed in Early Neural Progenitors and
Differentiating Neuroblasts.

Mouse NRAGE and ~

7 mRNA
5 expression
~
~
from
~
E l l through Adult

detected by serial section in situ hybridization. (A, G) NRAGE expression in the
neuroepithelium of the E l I cortex and the mantle zone of the spinal cord. (B, H)
NRAGE mRNA in the E l 5 cortex detected in the ventricular zone and subplate
and the mantle zone of the spinal cord. (C, I) Expression of NRAGE in the E l 6
cortex was detected in the ventricular zone, subplate, and cortical plate. (D)
NRAGE expression in the ventricular, cortical and subplate zones in the P I
cortex. (E) Transcripts are present in the dentate gyrus, C A I , CA3 regions of the
adult hippocampus (K) Within the adult cortex NRAGE mRNA is observed in
layers I-VI. (M) ~
(N) ~

7 was5detected
~
in~ the subventricular
~
zone of the E l Icortex.

7 was5specifically
~
~ localized
~
to the mantle of the spinal cord at E15. ( 0 )

Within the P I cortex, ~

7 was5 detected
~
in
~ the~subplate zone. (F, L, P) No

signal was detected in IVRAGE and ~

7 control
5 cortex.
~
~LEGEND:
~
CAI, CA3:

tracks of the hippocampus, CP: cortical plate, DG: dentate gyrus, MT: mantle
zone, SP: subplate, SBZ: subventricular zone, VZ: ventricular zone. Scale bars:
(A-E, G-K, M, N) 100 pm: (0,K) 50 pm: (F, L, P) 200 pm.

Moreover, no background or signal was detected when slides were pre-treated
with RNAse A and antisense probes utilized (data not shown).
Consistent with our Northern analysis, the E7 egg cylinder was found to
express NRAGE (data not shown). However, the invading syncytiotrophoblast,
the outer syncytial layer of the trophoblast that covers each chorionic villus of the
placenta, and surrounding uterine tissue also expressed NRAGE. The presence

of NRAGE in the syncytiotrophoblast is consistent with previous studies having
identified MAGE gene expression in placental tissue279.From E8 through E l l
NRAGE mRNA was identified in all regions of the developing neural tube (Fig.
5A). There was no apparent restriction of NRAGE expression to any particular
brain segment and within each region, high levels of expression were observed
throughout the neuroepithelium. Within the spinal cord, NRAGE was observed
within the mantle zone (Fig. 5G). Similarly, ~

7 gene
5 expression
~
~ during
~ early

neural development paralleled that of NRAGE. ~

7 message
5
~was detected
~
~ in

the subventricular zone (Fig. 5M) and within the mantle zone of the spinal cord
(data not shown).
This

pattern of

NRAGE tissue

expression was

observed

until

approximately E l 4 at which point a change in spatial distribution of message was
observed. By E15, a prominent band of NRAGE gene expression was detected
within the subplate and ventricular zone (Fig. 5B). The mantle zone of the spinal
cord continued to express NRAGE (Fig. 5H) as well as

(Fig. 5N). This

segregation was complete by €16 where distinct bands of NRAGE mRNA
expression are well defined within the ventricular, subplate and cortical plate
zones (Fig. 5C, I). These distinct cortical regions, cortical plate, subplate and
ventricular zone continued to express NRAGE mRNA into postnatal life (Fig. 5D,
J), whereas ~

7 was5 predominantly
~
~
restricted
~
to the subplate zone (Fig. 5 0 )

at this and subsequent ages.
The adult brain was also found to express NRAGE. Within the cortex,
NRAGE positive cells can be identified throughout layers I-VI (Fig. 5K). The

dentate gyrus, CAI and CA3 regions of the hippocampus are also major sources
of NRAGE mRNA in the adult brain (Fig. 5E). NRAGE mRNA was detected in
numerous brain structures including, but not limited to; the neocortex, striatum,
pallidum,

hippocampus,

thalamus,

hypothalamus,

tegmentum,

tectum,

cerebellum, pons, medulla and the spinal cord. NRAGE was also present in
neural structures such as the developing pituitary or Rathke's pouch, the optic
and olfactory neuroepithelium, dorsal root ganglia (DRG), superior cervical
ganglia and the sympathetic chain.

NRAGE Protein Undergoes Spatial Regulation.

NRAGE mRNA undergoes a gradual spatial restriction as development
progresses. We asked whether the protein follows the unique characteristics of
the mRNA. To this end, we performed immunohistochemistry on serial mouse
embryonic sections from E7 through adulthood. We utilized two distinct affinity
purified NRAGE polyclonal antibodies: one generated to the peptide residues
(53-295) of rat NRAGE and a second generated against peptides (31-396). The
antibodies cross-react with rat, mouse and human protein isoforms (data not
shown). There was no difference in the overall staining pattern using the two
distinct antibody species. The protein expression of NRAGE revealed a similar
distribution pattern to the mRNA. NRAGE protein was observable within the E7
egg cylinder and in the uterine tissue (data not shown). At E l 0 through E l 3
NRAGE, immunoreactive cells can be observed in the proliferative neural tube
(Fig. 6A, B).

Figure 6. NRAGE Protein Distribution Recapitulates the mRNA Expression.
Mouse NRAGE protein expression from E l 0 through E l 3 detected by
serial section immunohistochemistry. Panels A to F are embryos probed with aNRAGE antibody. Panels G represents a control slide probed with preimmunserium. LEGEND: DRG: Dorsal root ganglia: MT: mantle zone, VZ:
ventricular zone. Scale bars: (A) 200 pm: (M-0) 100 pm.

Like the mRNA, the mantle zone of the spinal cord also expressed NRAGE
protein (Fig. 6D). In addition to the CNS, neurotrophin sensitive populations in
peripheral nervous namely the DRG and sympathetic ganglia also express
NRAGE (Fig. 6 Dl F).

Complementary to the compartmentalization of NRAGE mRNA in the
neural tube, the protein also became restricted within distinct bands in the
cortical, subplate and ventricular zones at E l 5 (Fig. 6E). Furthermore, NRAGE
continued to be expressed within the mantle zone of the spinal cord (data not
shown). Like the mRNA, NRAGE protein was observed in various subpopulations
of cells including the neocortex, striaturn, pallidum, hippocampus, thalamus,
hypothalamus, tegmentum, tectum, cerebellum, pons, medulla and the spinal
cord. hIRAGE positive cells within the cortical and subplate zones may represent
migratory neuroblasts that have recently moved from the ventricular zone.
Therefore, NRAGE protein is present through the entire neuroepithelial wall
within each brain region during early neural development. However, by late
development cells within the proliferative ventricular zone and the transient
cortical and subplate zones express NRAGE protein.
In general, cells within the ventricular zone during early neurogenesis are
neural precursor cells. These cells migrate out as development progresses to
form the transient subplate and cortical plate zones. These rudimentary
structures act as building blocks to form the cortical laminae in the adult. The
localization of NRAGE to these layers prompted an investigation as to the cellular

specificity of IVRAGE expression. lmmunohistochemistry was performed on
developing cortical neural and glial cultures generated from E l 3 embryos to colocalize NRAGE protein expression with either the expression of the early neural
specific marker neurofilament-68 ( ~ ~ - 6 8 ) or
~ 'the
~ ~glial
~ "specific
~
marker glial
fibrillary acidic protein (GFAP). NRAGE expression was found in both the neural
and glial sub-populations. (Fig. 7A, B, Dl E).

NF-68

NRAGE

GFAP

NRAGE

AP2alb

NRAGE

Figure 7, NR4GE Protein i s Identified in Cultured Neuroblasts and not in
Post-mitotic Neurons.

lmmunocytochemistry for NRAGE in cortical cell cultures. (A) NF-68 was
used as a marker for early neural precursor development. (B) GFAP was used as
a marker for astrocytes. (C) MAP2alb was used as a marker for maturing
neurons. (D, E, F) cell stained for NRAGE. ( G ) Note: Early neural precursor cells
are NRAGE positive, whereas maturing postmitotic neurons fail to co-localize

NRAGE. Scale bar: (A-G) 100 pm

However, NRAGE protein did not co-localize with more mature neural markers
such as M A P ~ ~ I (Fig.
~ ~ " 7C, F, G) suggesting that post-mitotic or maturing
neurons attenuate or turn off the expression of NRAGE protein. Interestingly,
within a subset of MAP2alb positive neurons NRAGE was found to co-localize to
nuclear compartments that displayed pyknotic nuclei characteristic of cells
undergoing apoptosis (Fig. 8A).

MAP2A

Nestin

NP
4DIV

Figure 8. NRAGE Redistributes t o Nuclear and Perinuclear Compartments.
(A, B) Cortical neural progenitors were cultured in vitro for four days in
differentiation media and triple stained wi,th the postmitotic neuron marker
MAP2alb or the multipotential neural progenitor marker nestin (cyan), NRAGE
(green) and DNA (red). NRAGE positive piknotic nuclei can be observed in
MAP2alb expressing neurons (white arrows), where as hlRAGE is primarily
cytoplasmic in nestin positive neural progenitors, which display low levels of DNA
condensation (white arrows). (C-E) GFP or (F-H) NRAGE-GFP was transiently
over-expressed in P I 9 cells and subcellular distribution was monitored over a
period of 72 hours. Over the 72-hour period GFP can be observed in both the
cytoplasmic and nuclear compartments. NRAGE ini,tially occupies the cytoplasm
(nuclear condensation begins) and redistributes to the membrane and

perinuclear regions after 48 hours (nuclear fragmentation begins) with almost
complete co-localization to 'the nucleus by 72 hours (complete nuclear
fragmentation) Scale bar: (A-H) 50 pm

Moreover, NRAGE expression within multipotential neural progenitors was
primarily identified within the cytoplasm with little nuclear condensation observed
(Fig. 8B). To further, assess NRAGE subcellular redistribution we transiently
transfected NRAGE-GFP or GFP into P I 9 cells and observed fluorescence
localization over a 72-hour period. GFP was found to occupy both cytoplasmic
and nuclear compartments with no observable nuclear condensation over the 72hour period (Fig. 8C-E). However, within the first 24 hours NRAGE-GFP
expressing cells exhibited nuclear condensation with NRAGE expression
displaying a punctuate cytoplasmic distribution (Fig. 8F). By 48 hours NRAGE
was found primarily adjacent to the plasma membrane and a perinuclear
compartment with nuclear fragmentation beginning (Fig. 8G). At 72 hours

NRAGE localized to the fragmented nucleus (Fig. 8H). Therefore, these results
suggest that LIRAGE protein is not expressed within neural populations
undergoing active neurotrophin competitive programmed cell death, but within
neural progenitors undergoing terminal differentiation. Further research is
required to assess IVRAGE protein in more mature astrocytic or oligodendrocytes
cultures.
Collectively, these data demonstrate that during embryonic neurogenesis
in the CNS NRAGE spatial distribution is regulated at both the mRNA and

consequently at the protein level. NRAGE protein is expressed in all brain
regions. Within the cortex, NRAGE is specifically localized to the cortical,

subplate and ventricular zones. In the remainder of the brain, NRAGE is
expressed within both the ventricular and subventricular zones and is restricted

to neural precursors and immature neural populations.

N M G E Protein is Temporally Regulated Throughout Development.

NRAGE potentially has multifaceted functions and thus a description of
expression across development is expected to reflect endogenous physiological
activities, The spatial distribution data supports the bipatential role of NRAGE
during development. Therefore, a similar mechanism regulating the temporal
distribution of NRAGE is expected to reflect its diverse developmental regulation.

We therefore sought to characterize NRAGE mRNA and protein expression
patterns across development. Utilizing semiquantitative RT-PCR in conjunction
with Western blotting we analyzed the temporal expression of NRAGE message

and protein in most major embryonic and adult mouse tissues (for a complete list
of tissues assayed see Table l),

Table 1. Developmental Tissue Expression of NRAGE mRNA
PI

El0

El2

€74

El6

El8

€20

Brain

+

+

+

+

+

+

+

+

Cervical N.T.

+

+

+

+

+

+

+

+

Thoracic N.T.

+

+

+

+

+

+

+

+

N.A.

+

+

+

+

+

+

+

Heart

+

+

+

+

+

Liver

+

+

+

+

+

Lung

N.A.

N.A.

N.A.

+

+

Kidney

N.A.

N.A.

N.A.

+

t

Muscle

N.A.

N.A.

N.A.

+

+

Intestine

N.A.

N.A.

N.A.

+

+

Thyroid

N.A.

N.A.

N.A.

+

+

Thymus

N.A.

N.A.

N.A.

+

+

Spleen

N.A.

N.A.

N.A.

+

+

Blood

N.A.

N.A.

N.A.

N.A.

N.A.

Tissue

Sacral N.T.

Adult

Legend: NRAGE positive tissue: +, NRAGE negative tissue: -, Tissue not tested:
N.A. (not applicable)

NRAGE mRNA was identified at all developmental ages for each tissue
assessed with the exception of fetal and adult blood (Table 1). A common pattern
of mRNA expression was observed regardless of the tissue assessed. This is
demonstrated by the ratio of NRAGE message to actin message within the
nervous system. The relative level of NRAGE mRNA was constitutively
expressed 'throughout development (Fig. 9A, B).
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NRAGE Displays Tissue Specific Temporal Regulation.

(A) Ethidium bromide stained agarose gels of reverse transcription-

polymerase chain reaction (RT-PCR) products. First strand cDNA amplification of
\!RAGE resulting in a -800 bp fragment or -300 bp p-actin fragment and
Western blots of NRAGE with an approximate molecular weight of 97 KDa. Note

NRAGE mRNA was identified at all ages, whereas the protein is regulated in a
tissue specific manner. (B) The graph outlines the relative quantitation of NRAGE
mRNA across development as depicted from A. IVRAGE levels are equilibrated
to actin levels for each age and expressed as a ratio to the E l 0 NRAGElactin
levels, or E l 2 for the sacral neural tube. An n=4 for is represented in the graph.
(C) semi-quantitative RT-PCR analysis of B2+ sympathetic neuroblast NRAGE

gene expression. Graph is equilibrated in the same fashion as B with an n=4.
Note: NRAGE mRNA and protein levels peak concomitant in the thoracolumbar
region at approximately E14.

For every tissues examined, only minimal modulation in mRNA message was
observed during embryogenesis through adulthood. Intriguingly, a major
exception to this typical NRAGE mRNA profile occurred within the developing
thoracic neural tube. In the region that both the NGF dependent DRG and
sympathetic ganglia reside, there was an elevation in both protein and mRNA
message levels commencing at day E l 4 and again at E l 8 for the mRNA (Fig.

9B). Since our segments included several cell populations, we focused
specifically on the expression within the developing DRG and thoracolumbar
sympathetic chain over gestation (E14-E18). To this end, DRGs and B2+
sympathetic ne~~roblasts
were isolated and RNA and protein extracted. The level
of NRAGE message during gestation mimicked what was observed in our
thoracic neural tube segments except the elevation of NRAGE mRNA was
significantly enhanced (-3 fold) (Fig. 9C).Due to the limitation in cell number, we

were not able to quantify whether the raise in protein matched the rise in
message, but since a rise in protein was also detected in the thoracic section
studies we assume a significant rise in protein would follow.
Characterization of NRAGE protein expression demonstrates a distinct
pattern of tissue expression regulation compared to the mRNA. Unlike the
constitutive mRNA expression, the expression of NRAGE protein is under
stringent temporal regulation (Fig. 9A). Within the developing mouse nervous
system, NRAGE protein appears as early as E7 (first day examined) but by P I
unlike the rnRNA, protein levels were under the limits of detection, even after
prolonged exposure times and increasing the concentrations of the two NRAGE
specific antibodies used.
Specifically,

NRAGE protein levels were

identified

during

brain

development maximally at E9 through E l 0 and .then decreasing at E12,
remaining low until birth when the protein is virtually undetectable. The heaviest
staining of NRAGE protein was observed between E12-El4 in the thoracic
region, including dorsal root and sympathetic ganglia. Expression was detected
until E20, a key chronological landmark since trophic mediated survival begins as
early as E l 6 and continues into postnatal life3''. The presence of NRAGE protein
in this segment and within these neurotrophin sensitive populations supports a
role for NRAGE in this process, consistent to the observations of Salehi and
co~leagues'~~.
In the latter tissues, NRAGE appears to migrate as a doublet,
possibly reflecting post-translational protein modification. In the thoracic neural
tube, the upper band of this 97K doublet is particularly prominent at E16.

Possible phosphorylation andlor ubiquitination are currently being assessed as
an explanation for this shift in NRAGE expression. These data indicate that
despite constitutive levels of NRAGE message, the temporal expression of the
NRAGE protein constitutes the greatest level of regulation.

Discussion
Developmental

Expression

of

NADE,

NRlF

and

SC-1

During

Embryogenesis.
Our data demonstrate that primarily the ~ 7 5 ~ ~ ~ - i n t e r a cproteins,
ting
NADE, NRlF and SC-1 are expressed in concert with p7sNTR during
neurodevelopment. Temporally, the expression of ~

7 with5 these
~ three
~
~

effector proteins also supports their predicted roles as mediators of mitotic arrest
and apoptosis. What is most intriguing is the distinct expression patters displayed
by the two effectors putatively associated with apoptosis. NRlF levels decline

while the levels of NADE remain invariant during neurodevelopment. Since our
PCR analysis is a population assay we cannot ascertain the total message or
corresponding protein levels within individual cells. However, it is interesting to
speculate that the total amount of NADE and NRlF or perhaps the ratio of these
two proteins in conjunction with the expression of p75NTR,is what makes an
individual neuroblast or glioblast more or less susceptible to ~
apoptosis. In this way, ~

7 mediated
5
~

7 mediated
5
~cell death
~
~may be an early way to limit

the number of neuroblasts or glioblasts prior to overt differentiation, Trk induction
and the classic target derived neurotrophin mediated apoptosis seen in later

~

~

development. However, what may be more telling regarding the roles these
proteins play during development is that in addition to co-localization with p75NTR,
each gene is expressed in a unique pattern independent of

and each

other.
During development

is found in the transient subplate region of the

cortex, cholinergic neurons of the basal forebrain, nucleus basalis, striatum and
the motor columns of the spinal cord in murine and primate species138,313,320,321
In addition to expression in the CNS, ~

7 is 5found~ in the
~ peripheral
~

sympathetic and sensory neurons3209322. Within the nervous system, ~

7 has5

~

~

been shown to mediate a number of physiological and developmental events
including; apoptosis of cholinergic neuron in the neostriatum135z323, modulation of
the cholinergic forebrain neuron physiology324,and promotion of apoptosis in
seizure-induced rats within the hippocampus, piriform cortex, and entorhinal
cortex325.Moreover, retinal and mantle zone neurons are sensitive to ~ 7 5 ~ ~ ~ mediated apoptosis143.303 . p75NTRis also required for naturally occurring cell
death within the sympathetic and sensory g a n g ~ i a ' ~ ~ ~ The
' ~ ' ~ most
' ~ ~ . recent
report demonstrates that p75NTRknockout mice have severe nervous system
defects, and unexpectedly show a requirement for p75NTRexpression in vascular
development304.Even though expression of ~

7 in any
5 given
~ cell
~ population
~

does not predetermine whether apoptosis will occur, it is still important to address
the spatial and temporal relationships of ~
in order to better understand the functions of
during development.

7 and5~

~7 -interacting
~5
~~ proteins
~
~

and its interacting proteins

Consistent with the diverse expression pattern of p75NTR, all three
interacting proteins examined, NADE, NRIF, and SC-1 showed a widespread
tissue distribution. Within the brain, the localization of NADE, MRIF and SC-1 to
the subplate and cortical plate implicates an involvement in the development of
migratory maturing cells. The observation that ~

7 is neither
5
~ expressed
~
~ nor

required for apoptosis in these regions of the cortex does not diminish previously
characterized functions of known ~

7 interactors.
5
~ NADE
~ and
~ NRlF expression

coincide with the spatial arid temporal establishment of neural circuitry,
differentiation and synaptogenesis during developmental stages where high
levels of trophic-dependent apoptosis are occurring.
NRlF knockout mice were previously shown to be indistinguishable from
what has been observed in p75 N TR-I- and ngfl- mutants326.Our results support the
widespread gene expression reported by Casademunt and colleagues326.Similar
to NADE, NRlF demonstrates ~

7 concurrent
5
~ expression
~
~ in the subplate, optic

vesicles, otic vesicles, mantle zone of the spinal cord and sympathetic and
sensory ganglia. The strong correlation between NRlF and ~

7 expression
5
~

lends evidence to the relevance of NRlF as a bona fide ~ 7 5 ~ ~ ~ - i n t e r a cprotein
ting
mediating apoptosis in vivo. Interestingly, other zinc finger proteins have also
been shown to promote apoptosis and may work in concert with MRIF. Zacl a
tumor suppressor gene expressed in the brain was suggested as a model protein
whose function

may mimic NRIF's function via

a non-p75 mediated

A comparison of the expression domains of NRlF and Zacl

~

~

support this notion as NRlF and Zacl have reciprocal distribution patterns within
the brain327.
The zinc finger containing protein SC-1 has the greatest stringency in its
developmental expression profile. The tissue distribution is more refined than that
of NADE or NRIF. Within the CNS, SC-1 was identified most prominently in the
cortical and subplate regions and also in the mantle zone of the spinal cord.
Likewise, expression was observed in the peripheral ganglia. The level of SC-1
mRNA increased as development progressed, with maximal levels obtained only
in adulthood. SC-1 was originally identified and cloned in Schwann cells'49. Since
SC-1 is expressed in both the PNS and CNS, and glial formation follows neural
development, it is more likely than not that astrocytes andlor oligodendrocytes
are the main expressers of SC-1. However, the precise cellular resolution of SC1 expression in the brain remains to be determined.
We have described thus far the developmental regulation of three ~

7

5

interacting proteins; NADE, NRlF and SC-1. We demonstrated that each gene
has common developmental properties associated with ~

7 expression
5
~ and
~

function. In addition, novel in vivo roles were assessed for the unique expression
characteristics relevant to each gene. The most provocative and recurring feature
described to date involving any of the ~ 7 5 ~ ~ ~ - i n t e r a cgenes
t i n g has been the
identification of gene expression within the cortical plate. Therefore, the diverse
signaling potential during development for each of these three genes strongly
suggests a complex regulatory system underlying their overt characterized
physiological properties.

~

~

Developmental Expression of NRAGE During Embryogenesis.
We have analyzed the expression of NRAGE, a member of the evergrowing MAGE gene family, during murine embryogenesis in order to attempt to
correlate the gene expression with potential functions during development. Both
the mRNA and protein are widely expressed. NRAGE mRNA was identified at
the earliest embryonic day tested (E3) and the protein was found from E7
through adulthood, depending on the tissue assessed. The mRNA is
constitutively expressed from embryogenesis to adulthood. However, the protein
undergoes tissue specific structural and temporal regulation across development
suggesting that the strongest regulation of NRAGE expression is posttranscriptional. In the developing nervous system, peak levels (E12) occur during
early development when the brain and spinal cord are undergoing rapid
proliferation and expansion. NRAGE mRlVA and protein were apparent in all
brain regions with expression detected throughout the entire neuroepithelial wall
during early stages of neurogenesis. During later stages of neurogenesis,
NRAGE was specifically localized to the cortical plate, subplate plate and
ventricular zone of the cortex. Both the ventricular and subventricular zone of the
midbrain and hindbrain express hIRAGE and this expression is probably
restricted to neural precursors or immature neurons since NRAGE co-localizes
exclusively in within NF-68 positive cells. Localization of NRAGE to the
proliferative ventricular zone is suggestive of a role in cell cycle regulation or
early neural progenitors, whereas expression within the subplate and cortical

plate correlates with areas where post-mitotic neurons undergo cell death
mediated by the traditional neurotrophic hypothesis.
NRAGE, like its closest family members MAGEDI is expressed in most
tissues examined, supportive of a potential essential role for the cellular function
of NRAGE. However, elucidation of cellular function has proven difficult to assess
due to the very low levels of detectable endogenous and transfected protein
expression in a variety of primary and cell lines, e.g. COS7, PC12, P19, U87, C6,
MAH and 293 cells (S.K., D.G., and J.M.V. unpublished results). This narrow
range of accumulation of NRAGE protein in these cell lines indicates stringent
regulation for cell viability andlor normal cellular proliferation. Over-expression of
NRAGE protein appears to be toxic to recipient cells, and the proportion of
successfully transfected cells that express tagged NRAGE cDNAs is extremely
low. Taken together that transfected cells also reduces proliferative levels155it is
possible that only cells in a particular stage of their cell cycle allow for the overexpression of NRAGE. These results are in agreement with previous findings
from Casademunt and c o ~ l o g u e s ' ~indicating
~
poor cellular expression of
transfected NRIF, possibly via a cell cycle dependent mechanism.

In the PNS NRAGE Correlates with Sensory and Sympathetic Neuron
~

7 Mediated
5
~Apoptosis.
~
~

For neural tube development, NRAGE is present when motoneurons of
the floor plate are beginning to undergo trophic dependent programmed cell
death328and the lateral motor column shows high levels of ~

7 expression
5
~ at ~

~

this time329.NRAGE has previously been detected in m o t o n e ~ r o n s However,
~~~.
the importance of ~

7 mediating
5
~ apoptosis
~
~within motoneuron pools in vivo

has been questioned since

deficient mice fail to display any significant

loss in motoneuron populations138,322
The neural tube dissections allowed for the collection of both the
sympathetic and dorsal root ganglia. The presence and timing of expression of
Trk and ~

7 in both
5 these
~
structures
~
~
has been well documented308'37s329.330.

Moreover,

has been shown to be required for promoting apoptosis in

these neural

The timing of sensory and sympathetic

neurotrophic dependent cell death commences at approximately E l 4 and E l 7
r e s p e c t i v e ~ y ' ~ Unlike
~ ~ ~ ' ~the
. CNS where NRAGE protein is diminished prior to
the onset of neurotrophin mediated cell death, NRAGE is expressed in the DRGs
and sympathetic ganglia prior and during the period of programmed cell death.
The expression of NRAGE within the purified 62'

population of

sympathetic neuroblasts reveals an interesting insight into the potential function
of NRAGE in the PNS. Both hlRAGE protein and message are expressed in
sympathetic neuroblasts, yet ~

7 is only
5 expressed
~
~ after
~ the onset of mitotic

arrest'001329.
This means that if NRAGE mediates the cell cycle withdrawal of
committed neuroblasts it is through a p75 independent mechanism.
So what if any function does NRAGE and

interactions have in the

formation of the PNS? It is possible that N R A G E - work
~ ~ to
~ cull
~ ~neurons
~
that
reach their targets but have failed to reach sufficient levels of Trk on their cell
surface making apoptosis an instructed extrinsic event ( P ~ ~ ~ ~ ~ - N R as
AGE)

apposed to a default intrinsic pathway lacking NGF stimulation. This would be a
twist on the classical neurotrophic .theory in that neurons that do not receive
sufficient neurotrophic support from lack of Trk-NGF die as a consequence, but
also may be instructed to undergo apoptosis as a result of NGF- P ~ ~ ~ ~ ~ - N R A G E
activation.

In the CNS NRAGE Protein Expression Correlates with Timing of a p75NTRIndependent Neural Precursor Apoptosis.

During brain development NRAGE is present predominantly during the
stages when the ventricular and subventricular region are undergoing rapid
proliferation of neural precursor cells. Concomitant with differentiation and
migration of neuroblasts from the ventricular region, NRAGE localizes to this
proliferative layer. Although, the spatial distribution of NRAGE protein is largely
independent of ~
localize with ~

7 receptor
5
~expression
~
~within the brain NRAGE does co7 in the
5 subplate
~
~region.
~ ~

subplate in rat,

primate and

7 has5been~detected
~
within
~
the

human species cerebral

cortex324,332-334

Furthermore, p75NTRhas recently been show to promote survival of subplate
neurons in vitro in a Trk independent fashion335.In addition to the subplate,
- basal forebrain cholinergic neurons located in
NRAGE co-localizes with p75NTR In

the

medial

septum,

diagonal

band

of

Broca,

nucleus

basalis

and

striatum31333339336p337.
The basal forebrain has been shown to be sensitive to NGF
induced a p o p t ~ s i s ' ~ However,
~.
an involvement of NRAGE in mediating
apoptosis in the striatum has yet to be determined.

Taken together these results do not preclude the possibility that NRAGE is
involved in a ~ 7 5 ~ ~ ~ - m e d i neural
a t e d apoptosis. However, this does not seem
likely since NRAGE levels are significantly reduced during the timing of trophic
dependent apoptosis. However, the significant level of NRAGE in the ventricular
zone certainly indicates an ancillary function to that of ~ 7 5 Like
~ ~Necdin,
~ .

NRAGE functions as a growth arrest protein and may function in mediating
mitotic arrest when neuroblasts are beginning to differentiate and migrate from
the ventricular zone.
The fact that hIRAGE may possess roles apart from ~

7 during
5
~

development does not exclude a pro-apoptotic function in a cell cycle dependent
manner within the brain. Previous studies have shown that molecules acting
during cell cycles progression are required for apoptosis. These include mitotic
k i n a ~ e s ~ ~the
' , tumour suppressor gene p53 which is required for neural
D
precursor cell a p o p t o ~ i sand
~ ~cyclin
~

~ There
~ is~ growing
~ . support indicating

the existence of two functionally distinct types of programmed cell death in the
nervous system of developing mammals. This early neural cell death affects
neural precursor cells and young neuroblasts involved in an active mitotic cycle,
whereas trophic dependent cell death involves postmitotic neurons16. Recent
estimates indicate that between 50-70% of cortical neuroblasts in the proliferative
ventricular zone undergo apoptosis in murine and primate

While the

precise number of neural precursor cells undergoing apoptosis is under
debate26,'341-343

the importance of this developmental event has been inferred

from the studies of caspase-3, -9 and APAF-1 deficient mice. These knockout

~

~

mice all exhibit marked ventricular zone expansion32n33r3441345.
The selective
enlargement of the ventricular zone during early neurogenesis suggests that
caspase-3, -9 and APAF-1 functions are essential for apoptosis during early
development of the CNS and that in the absence of normal neural precursor
apoptosis cell development is abnormal346.Timing of neural precursor apoptosis
within the CNS is region specific, generally cell death commences at around E10,
reaching a peak around E14, and then decreasing postnatally to low levels seen
in the adult. This early-programmed cell death coincides very well with both the
spatial and temporal distribution of NRAGE. Taken together with the fact that
NRAGE levels peak just prior to the onset of the neural precursor apoptosis and
that concurrently the first cortical neurons are exiting the cell cycle at

it

becomes important to determine whether NRAGE may function as a molecular
switch between cell proliferation and apoptosis for neural precursor cells in the
developing mouse cerebral cortex.
Other studies are also consistent with the operation of extensive
neuroproliferative apoptosis related to the progression of the cell cycle.
Thomaidou and colleagues26 demonstrated that the commitment to die in the
developing ventricular zone of the cerebral cortex is integrally related to the G I to
S transition. A primary function in linking cell cycle and cell death is exerted by

proteins acting as cell cycle checkpoints. A key regulator of the G I to S transition

I ~ mice
~ ~ lacking E2F-1 have a suppressed level of a p o p t o ~ i sThe
~~~.
is E ~ F - and
p53 protein is another transcriptional regulator of the G I to S transition and is
also involved in promoting apoptosis of neural precursor cells in a caspase

dependent manner339.Thus, it appears that cell cycle proteins are important, for
at least some apoptotic mechanisms that result in the activation of caspases
during early neural cell death. However, further research is required to draw
definitive concludes pertaining to NRAGE activity during neural precursor
apoptosis.
NRAGE was also identified in many other non-neural tissues throughout
development. Similarly .the ~

7 receptor
5
is~ expressed
~
~in a variety of other non-

neural tissues, both in the embryo and the adult. The gross tissue distribution of
NRAGE is in agreement with the distribution of

previously characterized

in rats350v351.
However, our result also identified non-neural regions that are not
known to express ~ 7 5 Therefore,
~ ~ ~ these
.
results can be attributed to the
proposed diverse nature of NRAGE's endogenous function as a growth arrest
protein and as a mediator of a ~ 7 5 ~ ~ ~ - i n d e p e npro-apoptotic
dent
signaling factor.
Within the majority of tissues AIRAGE expression is correlated within
populations of renewable cells and immature differentiated phenotypes, for
example the testis (spermatozoa production), intestine (epithelial turnover), skin
(dermis), spleen (lymphocyte production), liver (hepatocyte turnover), pregnant
uterus, and olfactory bulb and neural precursor cells of the adult brain.
The expression of NRAGE throughout early stages of embryogenesis
suggests that this protein plays an important signaling role(s) in the development
of the neural tube, brain and many non-neural tissues as well. The function of
NRAGE at these early times may not be mediated through neurotrophin
interactions, as we observed in the thoracolumbar B2+ population. In this

population of purified sympathetic neuroblasts, hlRAGE expression correlates
~ ~ ~ .
with excite from the cell cycle prior to expression of Trk or ~ 7 5 However,
under strict spatial and temporal regulation when expressed in the presence of
p75NTR,NRAGE may mediate an NGF cell death-signaling cascade. This may be
a novel mechanism by, which sympathetic and presumable sensory neuroblasts
that do not express TrkA or insufficient levels of TrkA may be culled from the
population of innervating neuroblasts. When expressed in the absence of
under a different set of spatial, temporal and possibly structural regulations,
NRAGE may induce cell cycle arrest potentially leading to apoptosis through a

novel mechanism.

CHAPTER 3
NRAGE Regulates p38 Activation to Mediate the Transition Between BMP
Induced Apoptosis and Differentiation of Neural Progenitors.
Abstract
Understanding the molecular events that govern neural progenitor lineage
commitment, mitotic arrest and their differentiation into functional progeny are
germane to our comprehension of neocortical development. Bone morphogenetic
protein (BMP) farriily members play pivotal roles in regulating neural
differentiation and apoptosis during neurogenesis through either Smad and/or
TAKl activation. NRAGE posses the ability to function as a key component in the
TAKl signaling cascade stimulating p38 activation leading to the induction of

apoptosis. Loss of NRAGE function in multipotenital neural progenitors leads to
loss of neuronal differentiation potential through perturbation of progenitor
terminal mitosis. The capacity for NRAGE to modulate the cell cycle is well
observed through over-expression that results in a rapid GI-S arrest with an
aberrant S phase re-entry. These studies support a model in which NRAGE
server as a modulator of downstream signaling events affecting the balance
between cell cycle progression, differentiation and apoptosis.

Introduction
The pseudostratified neuroepithelium of the neural tube is generated from
neural progenitor cells located within the ventricular and subventricular (VZISVZ)
zones352.The fate of neural progenitors is defined by their microenvironment

including effects from extra-CNS tissues'783353-363.
The generation of specific
cellular phenotypes, neurons, astrocytes, radial glia and oligodendrocytes occur
during tightly regulated spatial and temporal windows throughout err~bryogenesis
and early postnatal life. Regulation is complex requiring transitional changes in
intrinsic cues and the availability of extrinsic growth, differentiation and survival
cues. Further complicating our understanding of stem cell progression from selfrenewing multipotential cell to differentiated progeny within the cortex, is the
increasing recognition that programmed cell death or apoptosis is a prominent
event regulating cell number throughout the entire pathway from stem cell to
neural progenitor to mature differentiated phenotype19,23,29,173.343.364-368. ~h e
regulation of cell numbers during all facets of neural development may be
important for the correct temporal and spatial generation of cell phenotypes and
consequently accurate brain morphogenesis.
The fate of neural progenitor cells is regulated in part by bone
morphogenetic protein (BMP), members of the transforming growth factor-p
superfamily. BMPs signal through heterotetrameric complex formations of type I
(BMPR-I) and type II (BMPR-II) serine-threonine kinase

The

"canonical" pathway activates Smadl, Smad5 and Smad4 proteins229,370,371
However, recently an alternative signaling pathway has been described in which
the X-linked inhibitor of apoptosis protein (XIAP) functions as an adaptor protein
bridging BMPR-la and TGF-P activated binding protein (TABI), an activator of
the MAPKKK TGF-P activated Kinase 1 ( T A K ~ ) ~
TAKI
~ ~activity
* ~ ~has~ been
~ ~ ~ ~ .

shown to promote the activation of p3821532171373
Jun N-terminal kinases

INKS)^'^,^^^, and Nemo-like k i n a ~ ae MAPK
~ ~ ~ family member.
The multiple functions of BMPs during embryogenesis and neural
development include complex actions upon the neural

rest^^^^^^^^^^"^^ , apoptosis

or differentiation of neurons and glia within the cortex'800'81,383-385
and dorsal
spinal

These apoptotic actions may be initiated through TAKA, which

induces apoptosis in the neuroepithelium of Xenopus embryos and this cell death
is inhibited by BCI-2214.
Another prominent regulator of cell death is XIAP, which
can directly bind and inhibit caspase

More recently, XIAP has been

shown to bind TABI, an activator of TAKA, and inhibit TAKA-induced
apoptosi~~~~.
Collectively these observations suggest that BMPs regulate fundamental
events during embryogenesis of the nervous system. The mechanism that
governs a seemingly paradoxical switch between morphogenesis and apoptosis
within the developing cortex remains unclear. However, recent work suggests
that during the onset of corticogenesis in the mouse at embryonic day 13 (E13),
high levels of BMPs (10-100 nglml) promote apoptosis and inhibit proliferation of
neural progenitor cells of the ventricular

Moreover, by the midpoint

of neurogenesis (E16), BMPs promote neural differentiation of neural
progenitors383.Work by McKay and colleagues384 describe a feed-forward
mechanism whereby BMP actions are first induced through BMPR-la and then
terminate through BMPR-lb. As cell surface levels of BMPR-lb exceed those of
BMPR-la, BMPs cause a termination response of either cell death or cell

differentiati~n~~~.
Concurrent with the transition from BMPR-la to BMPR-lb,
neural and glia progenitors are secreting BMPs thus directing both neurogenesis
and gliogenesis in a concentration-dependent manner to make the critical switch
to neurotrophin signals and related cytokines385,388.
NRAGE is a recently characterized Neurotrophin Receptor interacting
MAGE homologue, identified in a yeast two-hybrid screen for proteins that
interact with the intracellular domain of the p75 neurotrophin receptor ( ~ 7 5 ~ ~ ~ ) .
NRAGE was shown to mediate both cell cycle withdrawal and an NGF-specific
apoptosis in sympathetic precursor cells through p75NTR'55.
The developmental
characteristics of NRAGE revealed expression during early corticogenesis,
specifically in neural progenitors of the ventricular zone and in differentiating
neuroblast of the cortex, independent of ~

7 expression
5
~ and~concomitant
~
with

the spatial and temporal occurrence of BMP-mediated apopto~is~'~.
This p7sNTRindependent expression suggests an alternative signaling cascade that may
utilize NRAGE to regulate mitotic arrest and apoptosis of neural progenitors.
Supporting this alternative for diverse cellular functions, NRAGE augments
interleukin-3-withdrawal-induced apoptosis through binding endogenous X I A P ~ ~ ~
and NRAGE is involved in UNC5-HI induced apoptosis of neural progenitors294.
Based on the temporal and spatial appearance of NRAGE in the
ventricular zone, an active area of cell cycle withdrawal and BMP-induced
apoptosis, we investigated whether NRAGE was involved in these events during
cortical neurogenesis. Using a loss-of and gain-of-function approach, NRAGE
expression was shown to be a prerequisite to mediate apoptosis of neural

progenitors through a BMPR-la dependent pathway. Activation of BMPRs leads
to the formation of the XIAP-TAKI-TAB1 signaling cornplex in which IVRAGE is a
crucial component regulating p38 activity. The level of NRAGE protein
expression is critical in maintaining a balance between cell cycle progression and
apoptosis. Under low BMPR stimulation, there is a low expression of NRAGE
that facilitates the formation of a TAKI-TABI-XIAP-NRAGE complex that
activates p38, driving a transient progression through the cell cycle by directly
coupling growth arrest and cell cycle progression. Greater BNlPR activation leads
to the induction of NRAGE and at these elevated levels, NRAGE binds both
members of the SMAD and TAKI pathways triggering competitive and apposing
cell cycle dynamics to initiate p53 activation and neural progenitor apoptosis.
These abilities for NRAGE to regulate MAPK signaling and cell cycle progression
are fundamentally important for neural differentiation and maintenance of cell
number through gestation making NRAGE a key molecule during neocortical
development independent of its role in neurotrophin signaling events.

Material and Methods
Cell Culture.
P I 9 embryonal carcinoma cells were maintained in growth medium
consisting of a-MEM (Invitrogen), 7.5% heat-inactivated calf serum and 2.5%
heat-inactivated fetal calf serum (Hyclone) at 37OC in 5% C02. For apoptosis
assays cells seeded at a concentration of 1 X

l o 5 cells/ml

in bacteriological-

grade culture dishes in growth media supplemented with 1 pM all-trans retinoic

acid (RA) and/or 10 nglml recombinant BMP4 (R&D Systems) or without
supplementation between 1-4 days. For neural differentiation P I 9 cells were
grown as aggregates in the presence of 1 pM RA for 4 days, trypsinized and
transferred to fibronectin coated tissue culture dished in the absence of RA for an
additional 4 days.
Cortical neural progenitors were isolated from timed pregnant mice
sacrificed at E l 3 and .the embryos were aseptically removed and placed in
Hank's balanced salt solution (HBSS) (Invitrogen) supplemented with 10% fetal
bovine serum (FBS). Cerebral cortex was removed, freed of meninges, dispersed
with 0.05% trypsin-EDTA and filtered with 70 pm nylon cell strainers (VWR).
Cells were seeded ( 2 x 1 0 ~cellslml) as aggregates in a medium containing 38%
Neurobasal medium, 60% DMEMlF12, 2% FBS, N2 supplemented (Invitrogen)
and 0.4 pl/mL penicillin/streptomycin (Invitrogen).
Over-expression and Loss of Function Studies.

Over-expression studies were performed using mammalian expression
vectors containing NRAGE-EGFP, NRAGE-myc, and an empty vector-EGFP and
a dominant negative Smad5. Cells were transfected via Lipofectamine 2000 as
per the manufactures recommended protocol (lnvitrogen). Loss of function
studies employed the use of antisense morpholinos directed to the start sites of
the genes of interest (see table 2 for sequences, delivery and knockdown
efficiency) and delivered using EPEl as recommended by the manufacture (Gene
Tools).

Table2. Morpholino Sequences and Knockdown Efficiency
Morpholino

Sequence

Delivery

Knockdown

Efficiency

Efficiency

NRAGE

5'-GGTTTCTGAGCCATAGCTCTCGTC-3'

90%

80%

TAKA

5'-AGCGCCCTTCAGCCCGGAGCCC-3'

92%

85%

TAB1

5'-CAGGCTCCTCCTCTGCGCCGCCATC-3'

85%

91 %

XlAP

5'-CATCTTCTCTGGAAAATAGGACTTG-3'

88%

74%

Standard

5'-CCTCTTACCTCAGTTACAATTTATA -3'

90%

0%

*

Control

Morpholinos incorporated a fluorescein tag to identify cells that have taken up the
Morpholino sequence allowing purification of the population if required by
fluorescence activated cell sorting. The specific p38 MAPK antagonist SB
203580 was use at a concentration of 5 pM (Calbiochem).
Over-expression of wild-type and dominant negative BMPR-la constructs
was accomplished through the generation of retroviral particles. The 293 GPG
retroviral packaging cell line was a generous gift from Dr. Chris Naus (LIBC). 293

GPG cells were maintained in medium consisting of DMEM supplemented with
10% FBS, 100 Ulml penicillin, 100 pglml streptomycin, 300 pglml G418, 200
pglml puromycine, and 1.0 pglml tetracycline. To generate the retrovirus pSAPexpression vectors contain either wild-type or dominant negative BMPR-la were
transiently transfected in our 293 GPG packaging cell line using Lipofectarr~ine
2000. The supernatants were collected every 12-24 hours over a 4 day period.
All culture supernatants were filtered through 0.45 pm syringe-mounted filters.
Aliquots of 1.0 ml were storied at -80°C. Titration of retroviral supernatant was

performed using serial dilutions (1110) of the supernatant, percent EGFP positive
cells were determined using a BD FACS Calibur and taken as the ratio of viral
volume per ml (CFUIml). Cells were transfected with appropriate titers of
retrovirus using 1 pglml polybrene.
lmmunoblotting and Immunoprecipitation.
The following antibodies were used for biochemical analysis: a-NRAGE3+
396

(Salehi et al., 2000), a-Caspase-3 (Pharmingen), a-TAKI, a-p38, a-dp-p38,

a-JNKlI2, a-P-Actin (Sigma), a-XIAP, a-BMPR-la, a-BMPR-lb, a-SMADI, aSMAD5, a-TABI, a-GFP (Santa Cruz), a-klF~Bp65 (BD Biosciences), aphosphoserine, a-N-myc, a-pSMAD1, a-pRB, a-p-pRB, a-p53, a-p21waf1,a~ 2 7 ~(Upstate).
'~'
For biochemical analysis whole cell extracts were prepared
using Nonidet P-40 (NP-40) lysis buffer [ I 37 mM NaCI, 20 mM Tris (pH8.0), 0.5
mM EDTA, 10% Glycerol, 1% NP-401 containing a protease inhibitor cocktail
(Roche) supplemented with I m M sodium orthovanadate and 1.25 mM sodium
fluoride. Concentration of total soluble protein was measured using BCA Protein
Assay Kit (Pierce). Lysates were immunoprecipitated using 50 pg protein, 0.1 pI
(vlv) pansorbin (Calbiochem), 1 pg1mL a-N-Myc or a-GFP antibody overnight at
4OC. IPS were washed three times with lysis buffer and subjected to SDS-PAGE
immunoblotting. For either immunoblotting experiments or IPS 50 pg cell lysate
were subjected to 7-15% SDS-PAGE under reducing conditions. After semi-dry
transfer onto Immobilon-P (Millipore), membranes were probed with appropriate
primary antibody. Primary antibody detection was accomplished using an
appropriate secondary horseradish peroxidase conjugate lgGs (Jackson lmmuno

Research Laboratories Inc.), developed using a chemiluminescent reagent
(Amersham), and exposed to Fujifilm between 1 and 2 minutes.

Apoptosis and Cell Survival Assays.
The number of viable and nonviable cells was determined by trypan blue
exclusion. An equal volume of 0.4% trypan blue solution (Sigma) was added to
the medium and left for 1 minute. The numbers of stained and total cells were
then counted within 5 minutes using a hemocytometer. Graphed data represents
averages taken from four samples, denoting one replicate, and depicted as the
means 2 SD of four replicate experiments.
All apoptosis and fluorescence-activated cell sorting (FACS) analyses
used a Becton-Dickinson FACS Vantage SE cell sorter (Enterprise IIC laser
providing simultaneous 488 nm and 350nm output, Spectra Physics HeliumNeon Laser Provides 633 nm output). Annexin-V labeling utilizes the early
externalization of phosphatidylserine upon the outer leaflet of the plasma
membrane by its capacity to bind annexin-V in a calcium dependent manner.
Live cells were collected 24 or 48 hours post-apoptotic induction and labeled with
annexin-V biotin and subsequently detected using streptavidin-PE secondary
antibodies and analyzed using flow cytometry. For annexin-v assays 10 pg/mL 7actinomycin D was used as a cell impermeable vital dye discriminating early
apoptosis (annexin-V'l7-AAD') and late apoptosis or necrotic cell death (annexinV'17-AAD').

Additional measures of apoptosis employed the characterization of

mitochondria1 membrane permeability as determined by the Mitocapture assay

kit (Calbiochem) and analyzed using flow cytometry according to manufactures
specifications.
Cell Cycle Analysis.
For cell cycle analysis P I 9 cells over-expressing the genes of interest
were synchronized in GOIGI using standard serum withdrawal. Briefly cells were
cultured in serum free conditions for 6 hours, transfected in serum free conditions
for an additional 6 hours upon conclusion serum containing medium was
replaced and cells were permitted to grow for an additional 24, 48 or 72 hours.
Live cells were collected, stained using a hypotonic DNA staining solution [ I
mglml sodium citrate, 0.3% Triton-X100, 0.1 mglml propidium iodide, 20 pm/mL
RNAse A]~'' and DNA content was analyzed on a Becton-Dickinson FACS
Calibur using Modfit 2.0 software. NRAGE'~~'or

cells were gated

and DNA content was measured on FL2-area. The base line location of the
GOIGI peak was set for the control'GFP cells and determined independently for
each replicate.
Immunocytochemistry.
Adherent cultures were grown on fibronectin coated glass coverslips, after
4 days cells were fixed in 4% paraformaldehyde in PBS (10 minutes), rinsed in
PBS and labeled with the postmitotic neural markers MAP2a/b, the astrocyte
specific marker glial fibrillary acidic protein (GFAP) (Sigma) and Nestin which
labels multipotential progenitors (Pharmingen). Appropriate species and isotype
specific secondary antibodies conjugated to Rhodamine were used together with
the DNA binding dye Hoechst 33258 (Ipglml). Percentage of cell phenotypes

were obtained for each replicate as the average of four frames and graphed data
represented as the mean 2 SD of four replicates for each condition (NRAGE
knockdown and Control Morpholino).
Semi-quantitative RT-PCR.

Total RNA was isolated, treated wi.th 1 unit of ~ L d s eI at room
temperature and re-precipitated. First strand cDNA was synthesized from 5 pg
total RNA with Superscript I1 (Invitrogen) using an Oligo (dT)12-18(Invitrogen)
primer according to published procedures389.All PCR reactions were performed
in the linear range of amplification as determined empirically using 1 pL for each
cDNA sample generated. When ever possible primers were designed to cross an
intron-exon boarder to distinguish cDNA amplification from any potential genomic
contamination. Primer sequences and annealing temperatures are detailed in
table 3.
Table 3. RT-PCR Primer Sequences
Gene
Oct314

Hesl
Mash1

Forward primer 9-3'
ATGGCTGGACACCTGGCTTC
AGACT
AGAAGAGGCGAAGGGCAAG
AA
TCGGCACTGACTTTTGCGGC
TGCTTT

Reverse primer 3'-5'
GCCAGGCTCCTGATCAACAG
CATCA
CAAAAAACCTTGGCAGCCTC
T
GAAGCACGATCAAAGGGGG

Annealing
Temperature
63°C
54°C
56°C

ACGAA
Wnt-I

ACGTTGCTACTGGCACTGAC

CCATTTGCACTATCGCACAG

58OC

Neuro
Dl
MEF2A

TCAGCATCAATGGCAACT

TGACTCGCTCATGATGCGA

56°C

DIx5

CCGTCTCAGGAATCGCCAAC

TCACCCATGTGTCCATCCTC
A
GAAGGGGTGGTGGTACGGT
C
CTGAAAGCTGGCTGGCTGGT

54°C

MEF2C

AGAAATGCCGACAGCCTACA
A
AGCAAGAATACGATGCCATC

56°C
56°C

Msx2

P-Actin

ATTCGCCGCCGCCAAGACAT

TCTTTTCGCCTTGGCCCTTC

A

G

TGTTACCAACTGGGACGACA

CTCTCAGCTGTGGTGGTGAA

56°C

56°C

Cycling parameters were as follows: denaturing 94OC, 30 seconds, annealing
(primer specific see table 3), 30 seconds and extension at 72°C. Amplification
products were separated on a 1% agarose gel and visualized with ethidium
bromide. Gels depict representative experiments obtained from at least four
replicates from four separate RNA pools.
Statistics.
All data are presented as the means 2 SD of at least four independent
experiments. Significance was determined by Student's t-test.

Results

NRAGE is Required in the BMP Mediated RA-induced Apoptosis.
Since, NRAGE was expressed within the developing central nervous
system in the absence of p75 NTR389 we asked whether NRAGE played a key role
in the formation of the nervous system outside those roles mediated by
neurotrophins. Since apoptosis is a prominent event in the regulation of cell
number throughout the entire progression from stem cell to neural progenitor to
mature differentiated neural cell

and NRAGE has been shown in earlier

studies to mediate apoptosis in sympathetic precursor cells, we initially were
interested in deterrr~ining if NRAGE mediates apoptosis in the absence of
~ 7 5 ~ ~ ~ - r n e dneurotrophin
iate
signaling in embryonal carcinoma (P19) cells and

E l 3 cortical neural precursors as putative models for cortical progenitor
apoptosis. Much of the detailed information regarding the effect of BMP signaling
on neuroblast proliferation, differentiation and apoptosis has been garnered using
these model
devoid to ~

system^^^^,^^'"^^. P I 9 cells have previously been shown to be
7 receptor
5
expression
~
~
~during the first 4 days of RA and/or BMP4

induced apoptosis, but do up-regulate the receptor on post-mitotic neurons76,395,
Indeed, RT-PCR analysis demonstrates that early P I 9 cells treated to undergo
apoptosis through RA treatment fail to express ~

7 receptor
5
(Fig.
~
10A).
~
~

I

L

P I 9 RNBMP4 48 Hours

NP RNBMP4 48 Hours
R,

Figure 10. RA Induced Apoptosis is Mediated Through BMP Signaling.
(A) RNA was isolated from P I 9 cells treated with RA over a 4-day period

or RNA was isolated from E l 3 neural progenitors following 3 or 7 days of in vitro
differentiation. Note P I 9 cells do not express p75NTR,but post-mitotic neurons
cultured from mouse neural progenitors are ~

7 positive.
5
~(B, ~C) Dose
~

response curves were generated to determine effective dosages for the induction
of apoptosis using increasing concentration of either RA or BMP4. P I 9 cell

survival was measured using trypan blue exclusion after apoptotic induction with
10 nglml BMP4, 1 pM RA or both. Presented in (D) are the means 2 SD of four
independent experiments demonstrating that RA enhances the number of trypan
blue stained P I 9 cells using the BMP signaling pathway. (E, F) Presented are
representative FACS histograms of P I 9 and E l 3 cortical neural progenitors (NP)
treated with 10ngIml BMP4 and 1 pM RA. Also presented is a western analysis
demonstrating the extent of NRAGE suppression using NRAGE antisense
morpholinos relative to standard morpholino control. Note in both cortical
progenitors and P I 9 cells, suppression of NRAGE expression (NRAGE KD)
limits the percentage of annexin-v, apoptotic, cells.

Retinoic acid (RA)-induced apoptosis of cortical progenitors and EC cells
has been argued to occur via the BMP signaling pathway since BNIP4 and RA
appear to act synergistically to potentiate the apoptotic effect396. Using two
independent measures of cell survival, trypan blue exclusion and annexin-v
immunoreactivity, we found that, in agreement with the previous data396,cortical
neural progenitors (NP) and EC cell viability was greatly compromised when
treated with a combination of RA and BMP4 than when cells were treated with
either molecule alone (Fig. 10D). These results do not rule out the possibility that
the actions of BMP and RA are additive, perhaps due to distinct populations of
BMP-sensitive and RA-sensitive cells, nor does this result formally support the
hypothesis that RA leads to a BMP induced apoptosis as suggested by
Rodriquez-Leon and colleagues. In an attempt to demonstrate that RA actions

were mediated by BMP, we attempted to exacerbate the effects of RA on
developing neuroblasts by over-expressing BMPR-la and treating the resulting
cells with RA. Cell survival decreased precipitously (52% 2 2) to a level
comparable to that of the cells treated with RA and BMP4 (48% 2 1). In contrast
cells in which BMP signaling was diminished by the expression of a dominant
negative (dn) allele of BMPR-la, that expresses only the extracellular domain
and is signaling incompetent, cell viability in the presence of RA was enhanced
and approached the level of untreated controls (RA treated: 72% 2 2; RA +
dnBIWPR-la: 85% 2 1 pc 0.01; Untreated: 95% 2 1). Moreover, RT-PCR analysis
demonstrated that BMP2 and BMP4 transcripts were greatly elevated after 8
hours of RA exposure (data not shown). These results support the hypothesis
that RA-induced apoptosis of proliferating neuroblasts is mediated by the BNIP
signaling pathways.
We then asked if NRAGE had any role in mediating cell survival in either
cell system. Cell viability was greatly enhanced in W B M P 4 treated cells that
under-expressed NRAGE using specific antisense morpholinos (Fig. 10E,F).
Conversely, the vast majority of P I 9 cells over-expressing NRAGE underwent
cell death within 24 hours, even in the absence of RAlBMP4 treatment (Fig.
10D). The addition of RAlBMP only enhanced the effect and the time course of
apoptosis in NRAGE over-expressing cells. These data, taken together,
demonstrate that the cell death signal, initiated by RA and BNIP is relayed by the
BNIP signal transduction cascade and is mediated by NRAGE.

To further confirm the link between NRAGE and RAlBMP4 mediated
apoptosis, we examined the expression of NRAGE protein as a function of time
after W B M P 4 treatment. NRAGE protein levels rose sharply one day after
induction with W B M P (Fig. 11A) and in primary E l 3 cortical progenitors (Fig.
11B).

A

P I 9 Response
n n n

Y

Y

B

NP Response

Y

Figure 11. NRAGE is Required for the Activation of Caspase-3 by RAIBMP.
Lysate of P I 9 or NP cells harboring control morpholinos or NRAGE
morpholinos treated with RA, BMP4 or both were collected daily and subjected to
western analysis to determine the levels of MRAGE and active caspase-3 during
apoptosis. In the absence of NRAGE expression, caspase 3 is not active and this
correlates with enhanced cell survival.

Strikingly, this increase correlated with an increase in the levels of activated
Caspase-3 in both systems. The activation of Caspase-3 was abrogated in cells
where NRAGE levels were reduced (Fig. 1IA,B) and activation was conversely
enhanced in NRAGE over-expressing cells. These results suggest that IVRAGE
plays a pivotal role in mediating W B M P induction of Caspase-3 and apoptosis.

NRAGE lnteracts with Members of the BMP Signaling Cascade.

MRAGE's role in the RAIBMP induced apoptosis prorrlpted us to clarify the
function of NRAGE in the BMP signaling cascade. To this end, we performed
immunoprecipitation experiments using myc-tagged NRAGE over-expressed in
EC cells treated with BNIP4. Cell lysates were collected and Western analyses
were performed using antibodies against various merrlbers of ,the BNlP signaling
cascade. NRAGE was found to weakly associate with the BMP receptors BMPRII and BMPR-la, while it showed a strong association with BMPR-lb. Since both
BMPR-I and BMPR-II are capable of existing as a heterotetramer when
activated, immunoprecipitation of both type-l and type-ll receptors with NRAGE
was not unexpected (Fig. 12).

NRAGE-myc
pCDNA-myc

] + ~ - ~ + ~ - ~ + ~ - ~ + ~ - \ + ~ - \ + ~ - \ + ~ - \
I - I + I - I + I - I + I - I + I - I + I - I + I - I + I - I + I - I +
C

BMPR-la

BMPR-lb

XlAP

TAK1

TAB1

SMADl

I.L

4
SMADS

NFrBp65

Myc

Figure 12. NRAGE Strongly lnteracts with XIAP, TAKA, TAB1 and BMPR-lb.
Present is a western analysis of P I 9 cells transiently over-expressing full
length NRAGE construct tagged with Myc and treated with BMP4 for 24 hours.
lmmunoprecipitation of the resulting lysates using the myc tag were used to
precipitate potential NRAGE binding proteins. The resulting blots were probed for
various members of the BMP signaling cascade.

The predominant mode of BMP signaling within the cell utilizes members
of the Smad family. As a result, we also looked at NRAGE interaction with these
proteins. Both Smadl and Smad5 were found to only weakly associate with the
NRAGE complex. Interestingly, NRAGE was found to strongly interact with
TAKA, TAB1 and XIAP (Fig. 12). These proteins are all members of a lesserknown pathway downstream of the BMP receptors. Previous reports have shown
that TAB1 (TGF-0 activated binding protein) activates TAKI (MAPKKK TGF-P
activated kinase I ) , which, in turn, promotes the activation of p38. XIAP (X-linked
inhibitor of apoptosis) appears to be required to functionally bridge TAKI-TABIp38 signaling through BMPR. Interestingly, over-expression of XIAP enhances
TAKA-p38 signaling, but inhibits TAKI mediated apoptosis suggesting a complex
regulatory mechanism245.NRAGE interaction with these members of the BMP
signaling pathway is specific since there was no interaction between NRAGE and
BMP independent TAKI binding proteins NF-kpp65 and Bcl-2 (Fig. 12, data not
shown), suggesting that the main mode of BMP apoptotic activity is through this
non-canonical signaling pathway of TAKI , TAB1 and XIAP.
The interaction between NRAGE, TAKA, XIAP and TAB1 appears to be a
functional one since NRAGE serine phosphorylation is reduced in cells where
levels of XIAP, TAKI or TAB1 were reduced. Using immunoprecipitation followed
by Western blot analysis with anti-phosphoserine antibodies, it was determined
that in the presence of BMP4, serine phosphorylation of NRAGE was enhanced
relative to that observed in unstimulated cells. If however, the experiment was

repeated under conditions

limiting XIAP,

TAKI

or TAB1

expression,

phosphorylation of NRAGE was significantly reduced (Fig. 13A).
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Figure 13.

The TAKI, TAB1 and XIAP Complex Promotes NRAGE

Phosphorylation.
(A) BMP4 treatment enhanced the serine phosphorylation of NRAGE in a
XIAP-, TAKI-, TABI-dependent manner. Protein lysates were generated from
BMP4 treated P I 9 cells over-expressing NRAGE and harboring antisense
morpholinos against TABI, TAKA, or control (see methods and table 2). 'The
resulting lysates were immunoprecipated for NRAGE and immunoblotted for
phosphoserine. (6) Western analysis demonstrating the effectiveness of TABI,
TAKl and XIAP morpholinos.

A Reduction in protein levels as a result of morpholino exposure was evident as
early as 24 hours after treatment (Fig. 13B). These results suggest that NRAGE,
XIAP, TAKI and TAB1 form a complex that promotes NRAGE phosphorylation
and activation.

~

NRAGE Regulates BMP-linked Apoptosis via the BMP Target, p38 MAP
Kinase.
Serine phosphorylation of NRAGE potentially leads to its activation, but
the putative targets of activated NRAGE still remained to be determined. p38
MAP Kinase is a target of the BMP signaling cascade that has been shown
necessary for the apoptotic response in various cell types. We hypothesized that
the effect of NRAGE on the BMP mediated apoptosis might also occur via this
prominent downstream regulator. To demonstrate that NRAGE is required for the
activation of p38 by BMP4, we looked at p38 phosphorylation in cells expressing
NRAGE at normal and reduced levels. We also monitored p38 phosphorylation
as a function of TAKI levels. This latter experiment functions as a positive
control, since TAKI is a known upstream regulator of p38. As expected,
reduction of TAKI expression via antisense morpholinos drastically perturbed
activation of p38 (Fig. 14A).
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Figure 14. NRAGE is Required for the Activation of p38 MAPK.
(A) Western blotting was used to detect active, doubly phosphorylated p38
in control cells and cells treated with either TAK or NRAGE morpholinos.
Although all cells expressed similar levels of inactive p38, only control cells
showed phosphorylation of p38. Reduced levels of AIRAGE or TAKI inhibited the
appearance of active p38. In contrast, treatment with IVRAGE morpholinos had

no effect on the canonical BMP pathway as indicated by the appearance of
active SMAD-1. JNK was not activated as a result of BMP4 treatment. (B)
NRAGE-myc was transiently over-expressed and cells were treated with or
without BMP4, cell lysates were collected and immunoprecipitated. Note BMP4
treatment facilitates BMPR-la complex formation, whereas in the absence of
ligand NRAGE interacts only minimal with receptor components. (C) Endogenous
NRAGE was immunoprecipitated following BMP4 treatment from NP cells. Only
in the presence of BMP4 does NRAGE interact with BlWPR and its associated
effects.

More importantly, we found a similar reduction in p38 activation in cells in which
TAK? expression was normal but NRAGE levels were diminished, suggesting
that like TAKA, IVRAGE is a key upstream and perhaps direct regulator of p38
activity (Fig. 14A). The down regulation of NRAGE expression appeared to have
a specific effect on p38 activation, as there was no change in the activation of
Smad-I nor was JNK activated as a result of BMP4 treatment (Fig. 14A). These
results demonstrate that the induction of cell death by BMP is accomplished
through hIRAGE's regulation of p38 activity.
We made an initial observation that when NRAGE was over-expressed,
application of BMP4 significantly enhanced the capacity for NRAGE to associate
with members of the BNlP signaling cascade (Fig. 12). However, in the absence
of ligand stimulation, prolonged NRAGE over-expression results in cellular
apoptosis suggesting that accumulation of NRAGE can force activation of the

BNlP signaling complex. However, in the absence of BMP4 NRAGE overexpression was found to interact only weekly with the receptor and its signaling
components (Fig. 14B). Exogenous NRAGE over-expression exceeds the level
of naturally occurring NRAGE within a cell and though over-expression exceeds
physiological levels it highlights the important binding capacities for NRAGE
under changing cellular circumstances. We therefore, wish to assess the binding
interactions of endogenous NRAGE to the BMP signaling complex in the
presence and absence of BMP4 treatment. Endogenous NRAGE IP from neural
progenitors was found to associate with BMPR-la and XIAP, TAKl and TAB1
only in the presence of BMP4 (Fig. 14C). Collectively, these results suggest that
in the absence of an instructive apoptotic cue NRAGE remains inactive.
However, following induction of apoptosis NRAGE functions in an instructive
manner signaling apoptosis through BMP. As the cellular levels of NRAGE
elevate the capacity for NRAGE to associate with the BMP signaling complex is
enhanced leading to p38 activation and apoptosis.
Having established a potential connection between BNlP signaling and
NRAGE activation of p38 leading to cellular apoptosis in cortical progenitors (Fig
IOF), we performed a series of similar experiments using neural progenitor cells
as they succumb to the apoptotic actions of RA and BMP in a similar manner.
We have previously shown that diminishing NRAGE expression in both cell
systems attenuates BMP apoptotic events perhaps NRAGE activates p38 within
proliferating primary progenitors. Indeed the addition of SB203580 to neural

progenitor cells in the presence of RAlBMP resulted in attenuation of p38
activation and enhanced cell survival (Fig. 15).
_

NP RAIBMP4 48 Hours

Figure 15. Neural Progenitors Require p38 MAPK to Mediate Apoptosis.
Annexin-V labeling was used to detect neural progenitor cells undergoing
apoptosis in control, W B M P or W B M P in the presence of the p38 inhibitor SB
203580 (5pm). Presented in are the X 2 SD of four experiments demonstrating
that inactivation of p38 rescues cells from apoptosis *p<0.01.

To further confirm a role for NRAGE in RAIBMP mediated apoptosis, we
induced apoptosis in P I 9 cells by over-expressing NRAGE and tested the effect
of treatment with the specific p38 inhibitor, SB203580. Annexin-V labeling was
used to detect cells in early phases of apoptosis (hlRAGE-GFP'Iannexin-V'l7AAD-), and flow cytometry was subsequently used to quantify the number of
living NRAGE-GFP' cells. In cultures over-expressing NRAGE after 48 hours,
57% 2 8 of the cells were annexin-V immunoreactive, a significantly greater

number than the 1 2 2% observed in the control cell GFP-expressing population
(Fig. 16D).
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Figure

16. RAIBMP4 and

NRAGE Over-expression Exhibit Similar

Functional Requirements to Mediate Apoptosis.
(A-C) Reducing the expression of the canonical and non-canonical BMP

signaling cascade abrogates NRAGE's ability and BMPs ability to induce
apoptosis in PI9 cells. (D-F) When P I 9 cells expressing full-length NRAGE are
deprived of canonical and non-canonical BMP signaling component apoptosis is
efficiently reduced. In both paradigms annexin-V immunohistochemistry was
measured by FACS. Presented are representative profiles of annexin-V positive
cells in each condition with the X + SD of four separate experiments.

On the other hand, the NRAGE over-expressing cell population treated with the
p38 antagonist, SB203580, showed an irr~pressiverate of survival 10% 2 9 (Fig.

16E). In addition, using the specific caspase-3 inhibitor Z-DQMD-FMK greatly
enhanced the cell survival (1% 2 1) when NRAGE was over-expressed (Fig.
16F). In other words, inhibition of p38 or the caspase cascade effectively
prevented apoptosis in these NRAGE over-expressing EC cells. Interesting, the
apoptosis induced through p38 was dependent on both TAKI and Smad5
signaling as abrogation of either molecule significantly reduced the level of cell
death observed (TAKI KD, 26% 2 4; Smad5 DN, 24% 2 7) (Fig. 16D).
As a final insurance for the involvement of NRAGE in BMP mediated
apoptosis we treated our P I 9 cells with RAlBMP4 for a period of 48 hours and
subsequently determined the requirements for BMP signaling as an instructive
apoptotic cue. As was found with NRAGE over-expression, both TAKI and
Smad5 signaling are an absolute requirement for the induction of apoptosis
(TAKI KD, 3% 2 6; Smad5 DN, 8% 2 3) (Fig. 16A). Furthermore, activation of
p38 is also an important regulatory event, as inhibition of p38 by SB203580 was
effective in reducing the level of cell death (24% 2 7) (Fig. 16B), as was inhibition
of caspase-3 (0.6% 2 3) (Fig. 16C). Collectively, these studies demarcate
NRAGE as a pivotal and necessary molecule in mediating the apoptotic effects of
BMP in the developing central nervous system.

NRAGE Regulates the GI-S Cell Cycle Transition.
Recent data suggests that uncoordinated expression of cell cycle
molecules and the consequent breach of cell cycle checkpoints could be one of
the primary mechanisms by which neural progenitors undergo apoptotic death
during terminal exit from the cell cycle. Evidence indicates that up-regulation of

cyclin/cyclin dependent kinase activity at the G I to S transition and deregulation
of E2F transcription factors mark early stages of neuronal a p o p t o ~ i sApoptotic
~~.
signals promote successive phosphorylation and dysfunction of Rb family
members, resulting in sequential E2F deregulation and expression of selective
E2F-responsive genes. The MAPK p38 influences cells throughout all stages of
the cell cycle (GI-M). Recent work suggests that p38 activation is vital to cell
cycle regulation and apoptosis of neuronal and non-neuronal cells types

397-400

Initiation of apoptosis was found to inactivate Rb by direct utilization of p38 in a
cyclin independent manner resulting in unscheduled re-entry into S phase401,402
Since NRAGE can positively regulate p38 activity and has previously been
shown to promote growth arrest, we assessed NRAGE's capacity to regulate
transitions through

the

cell

cycle.

Cells

over-expressing

NRAGE-GFP

( N R A G E ' ~ ~were
~ ) analyzed for DNA content by flow cytometry at 24, 48 and 72
post-transfection. After 24 hours NRAGE'~~'cells exhibited an enhanced
accumulation in G2-M (44 2 3%)"relative to P I 9 cells transfected with GFP
(control+GFP)
(35 2 2%; t=7.2, p> 0.04) (Fig. 17A,B).
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Figure 17. NRAGE Facilitates both Growth Arrest and Progression Through

S Phase.
(A,B) NRAGE-GFP was over-expressed, cells were collected 24, 48, and
72 hours post-transfection and their cell cycle profile was analyzed using flow
cytometry. After 24 hours NRAGE was driving progression through the S phase
with cells accumulating at the G2-IV1 transition. However, by 48-72 hours NRAGE
was facilitating a potent GI-S arrest. ( C ) Disruption of p38 signaling facilitates a

rapid G1 arrest in the presence of BMP4. (D, E) Treatment with either SB203580
or BMP4 along does not significantly affect the cell cycle (F) Over-expression of
both NRAGE and dominant negative Smad5 results in cells accumulating in the
G2 phase. (G) Whereas, over-expression of DN Smad5 along does not
significant affect the cell cycle. Collectively, these results demonstrate the
capacity to functional separate NRAGE mediated cell cycle events depending on
the either p38 or Smad signaling.

By 48 hours the majority (55 2 1%) of NRAGE'~~'cells were positioned at the
GI-S transition compared to just 43 2 2% (t=9.6, p>0.02) for control cells. The
percentage of cells at GI-S after 72 hours was further enhanced (64 5 4%)
compared to GFP controls (39 2 4%; t=12.3, p>0.01). These results coincide with
previous reports suggesting NRAGE acts as a growth arrest protein (Salehi et al.,
2000).
However, the unique bi-functional growth arrest observed within the first 24
hours provides a provocative insight into the function of NRAGE. We have
established that NRAGE is a critical component of the XIAP-TAK1-TAB1
signaling cascade leading to the activation of p38. Taken with the fact that Smad
signaling is a fundamental requirement for the mitotic arrest of neural progenitors
through suppressing c-myc promoter activity by dissociating p300 from E2Fs
providing accumulation of p2 1

. We hypothesized that in the
p2i'kip1403-405

absence of p38 Smad signaling would dominate providing an immediate G I
arrest. In support of this we found that NRAGE over-expressing cells treated with

the p38 antagonist SB 203580 displayed a subtle G I growth arrest (data not
shown). However, with the addition of exogenously added BMP4 N R A G E ' ~ ~ ~ S B
203580 treated cells rapidly exited the cell cycle displaying a prominent G I
arrest, which is maintained over the 72 hour period (Fig. 17C). Furthermore,
through the use of a dominant negative Smad5, NRAGE over-expressing cells
underwent a dramatic and maintained G2 arrest (Fig. 17F), a direct result of
unfettered p38 activity. These findings demonstrate the capability to disassociate
specific aspects of NRAGE mediated cell cycle control revealing an antagonistic
bi-potential function of BlblP signaling. This novel cell cycle control provides an
attractive model where by altering levels of BMP stimulation a neural progenitor
receives, a dynamic interplay between growth arrest and cell cycle progression is
created.
NRAGE Promotes a p53 Dependent Apoptosis.

The observation that NRAGE mediated apoptosis requires both Smad and
TAKl signaling which possess opposing cell cycle properties suggest that the
induction of apoptosis is dependent on perturbation of the cell cycle. Cell cycle
and apoptosis share common participants such as Rb, E2F and ~ 5 3 ~ This
'.
aberrant S phase reentry stimulated by NRAGE may be the underling cause of
the pro-apoptotic action of NRAGE. Taken with the fact that there is an intimate
link between cell cycle and apoptosis most often leading to induction of p53 when
control is lost we wished to address the contributions of p53 to an RAIBNIP and
NRAGE mediated apoptosis. EC control cells or p53 knockdown cells were
treated to undergo apoptosis using our standard RAlBMP technique, following a

48 hour treatment window cells were collected and stained for annexin-V and

subsequently analyzed using FACS. Abrogation of p53 was effective in
preserving cell viability, likewise, NRAGE mediated apoptosis was found to
require p53 (Fig. 18A).
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Figure 18. NRAGE Mediated Apoptosis is p53 Dependent.
(A) p53 knockdown or control morpholinos were introduced into P19 cells,

which were treated with RAIBMP4 or transiently transfected with NRAGE-GFP,
and the percentage apoptosis was determined using annexin-v binding. Both
RAIBIVIP4 and IVRAGE-GFP induced apoptosis require p53 as a necessary
component for cell death signaling. (B) NRAGE'~~'cells were purified using
FACS 24, 48 and 72 post-transfection. Cell lysates were collected and subjected
the standard Western blotting techniques. NRAGE initially triggers activation of

p38. However, p38 is gradually inactivated concurrent with the activation of Rb
and p53. A direct consequence of activation Rb and p53 is accumulation of
p21

and ~ 2 7 ~ ' ~ ' .

To further elucidate changes in cell cycle machinery, cell lysates were collected
from FACS purified NRAGE'~~'and control'GFP cells after 24, 48 and 72 hour
post-transfection and then subjected to standard Western analysis. During the
initial 48 hours activated p38 accumulated, consistent with the G2-M arrest,
however between 48 and 72 hours active p38 was rapidly turned off, consistent
with the G I arrest (Fig. 18B). The growth arrest observed after 48 hours of
NRAGE over-expression coincides with the inactivation of p38 and the losses off
the inactive hyperphosphorylated form of Rb. The activation of Rb may contribute
to the accumulation of the cdk inhibitors p2lWaf1and ~ 2 7 ~with
' ~ a' sharp elevation
in the phosphorylated state by 72 hours. These results are consistent with
NRAGE'~~' induced GI-S arrest after 72 hours. In addition, p53 levels
accumulate as time progressed; supporting the p53 dependence on NRAGE+GFP
mediated apoptos?~.These results demonstrate an antagonizing bi-functional
positive feedback loop in which th'e accumulation of cellular NRAGE enhance
progression through the cell cycle in a p38 dependent manner, concurrently
stimulating Smad dependent cell cycle withdrawal. Collectively these results
demonstrate that NRAGE facilitates apoptosis in a cell cycle dependent manner
leading to the accumulation and activation of p53.

NRAGE i s Required for the Cell Cycle Arrest and Differentiation of
Multipotent Progenitors.
Terminal differentiation of post-mitotic neurons required exit from the cell
cycle with increasing evidence Rb family members function as key regulators.
Failure to exit the cell cycle at the appropriate time leads to apoptosis. This
coupled relationship between cell cycle and differentiation is modulated at
multiple stages during the development to mature cells and the aberrant
deregulation of Rb during NRAGE cell cycle withdrawal suggests that NRAGE
plays a key role as a regulator of terminal differentiation and apoptosis. Taking
advantage of the differentiative potential of P I 9 cells, antisense NRAGE
morpholinos or control morpholinos were used to knockdown NRAGE protein
expression. Cells were then differentiated with RA to induce neurogenesis and
the percentage of post-mitotic neurons was calculated using MAP2alb
expression, astrocytes were detected by GFAP expression and proliferative
multipoint neural progenitors by nestin. Loss of NRAGE expression drastically
perturbed the generation of neurons and this deficit appeared to be the result of a
failure of neural progenitor cell cycle withdrawal (Figure 19A).
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Figure 19. NRAGE Mediates the Transition of Multipotential Neural
Progenitors to Post-mitotic Neuron.

(A) P I 9 embryonal carcinoma control or NRAGE knockdown cells were
differentiated with RA for 4 days and then cultured for an additional 4 days
without RA. Then subsequently stained for the post-mitotic neuron marker
MAP2a/b, the glial marker GFAP and nestin for multipotential neural progenitors.
In the absence of NRAGE post-mitotic neurons failed to be generated and this

deficit resulted in the accumulation of neural progenitors. Glial differentiation
remained unaffected. To assess whether the inhibition was a resulted of
perturbation in pro-neural gene expression RT-PCR was performed on RA
stimulated control and NRAGE knockdown cells cultured as aggregates between
1-4 days. (B) Both Oct314 and Hesl gene expression were elevated suggesting
NRAGE knockdown cells remain as pluripotent neural progenitors. Interesting,
loss of NRAGE did accelerates the onset of early pro-neural gene expression
and BMP regulated genes. However, the expression of later pro-neural gene
expression like MEF2A and MEF2C was abolished. Collectively, these results
demonstrate the requirement for .NRAGE to mediate the transition of neural
progenitor to post-mitotic neuron.

The deficit was at the sole expense of neurogenesis as evident by an increase of
32 5 5% in the number of multipotent progenitors with the ratio of glia remaining
unaffected. Therefore, NRAGE appears to be a key component regulating the
transition of multipotent progenitors to differentiated phenotype.
To determine whether this inhibition in differentiation was a direct result in
failure to induce appropriate gene expression RNA was collected on days 1
through 4 of differentiation and semi-quantitative RT-PCR was performed. During
RA treated cultures NRAGE knockdown did not inhibit the induction of pro-neural
gene expression (Figure 19B). In fact the loss of NRAGE accelerated RA
regulated gene expression by 24 hours. Furthermore, using Oct314 as a general
measure of the state of "sternness" and Hesl as a determinant of the frequency

of neural progenitors, NRAGE knockdown cells appeared to expand or maintain
cells in a multipotent state. This enhanced neurogenic gene expression is in
agreement with data obtained from neurogenesis of ES as a direct result of
prolonged Oct314 e x p r e ~ s i o n ~and
' ~ loss of p38 activity4". Therefore, the
apparent incapacity to generate post-mitotic neurons in NRAGE knockdown cells
is not a deficit in early pro-neural gene expression per se, but may reflect an
imbalance between early pro-neural genes and antagonistic bHLH factors like
Hesl and Hes5. Indeed, Hesl levels are elevated to inappropriate levels as a
result of loss of NRAGE (Fig. 196). This imbalance may directly contribute to the
loss of late neurogenic genes like MEF2NC as NRAGE knockdown greatly
perturbs the genesis of these transcription factors (Fig. 19B). Whereas,
MEF2BlD transcription factors, which are not involved in neural progenitor
differentiation, their gene expression remain unaffected by NRAGE knockdown
(data not shown). Importantly, MEF2NC has been shown to be an absoll~te
requirement regulating both myogenesis and neurogenesis in a cell cycle
dependent manner408410.
The loss of MEF2C is arguably a contributing factor
associated with the neurogenic deficit. Taken with the demonstration that
NRAGE is a potent regulator of the cell cycle, we conclude that the neurogenic
deficit is a result of failure to generate post-mitotic neuron in an NRAGE-cellcycle dependent manner.
To further corroborate our finding we challenged sorted IvRAGE'~~'or
control'GFPexpressing cells to differentiate in the presence of RA. As NRAGE is
a potent inducer of apoptosis we maintained our cultures in the presence of the

specific caspase-3 inhibitor Z-DQMD-FMK. The overall level of neurogenesis
was reduced for both our cultures, suggesting a basal level of active caspase-3 is
required for the transition of stem cell to neural stem cell, however this inhibition
was not absolute. In agreement with a pro-neural contribution, IVRAGE overexpression significantly enhanced the number of post-mitotic neurons generated
and this increase in neurogenesis cooperatively reduced the neural progenitor
pool (Fig. 20).
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Figure 20. NRAGE Over-expression Facilitates Neurogenesis

IVRAGE-GFP and GFP EC cells were sorted by FACS and differentiated
under standard RA conditions. As NRAGE over-expression is highly apoptotic
cultures were maintained in the presence of a specific caspase-3 inhibitor. Note
the enhanced neurogenesis as consequence of NRAGE over-expression. The
increase in NRAGE drives NP out of the cell cycle early and thus reduces the
overall number of NP present.

Therefore our results collectively demonstrate that NRAGE is required for the
terrr~inaldifferentiation of neural progenitors to post-mitotic neuron and inhibition
of NRAGE activity is fatal to neurogenesis. However, NRAGE levels and activity

must be strictly regulated as failure to so quickly changes NRAGE from a prodifferentiation to pro-apoptotic molecule.

Discussion
The presence of apoptosis in the proliferative neuroepithelium raises the
question of how the balance between maintenance and depletion of the
progenitor

pool

size

is

appropriately

controlled

by

the

extracellular

environment346.To elucidate the specific features of neural progenitor apoptosis
during neocortical development, we took advantage of primary cortical
progenitors and the P I 9 cell line. P I 9 cells differentiate into neurons and glia
when grown in the presence of RA4I1. In addition to differentiation, RA also
~'~.
induces activation of caspase-9 and 3 promoting a p o p t ~ s i s ~ ' * - Furthermore,
the apoptotic action of RA is facilitated by the addition of BMP2 or
The actions of RA mediate apoptosis through the RA receptor a and y417, which
promote the transcription of BMP2 and BMP4418.419 .
In this study, we shown that NRAGE is a necessary and sufficient
mediator of RAlBMP induced apoptosis in both cortical progenitors and P I 9
cells. The RAlBMP apoptotic signal requires the activation of BMPR-la and
subsequent formation of an NRAGE signaling complex involving XIAP, TAKI and
TABI. NRAGE, which has been shown in the peripheral nervous system to
mediate cell cycle withdrawal and

cell survival, is here shown to also

take part in BMP regulation of progenitor cell number in the forming cortex.
NRAGE functions to mediate apoptosis by forming a complex with members of

the non-canonical BMP signaling cascade TAKI, TAB1 and XIAP.

This

interaction leads to serine phosphorylation of NRAGE and activation of p38 and
the caspase cascade leading to cell death. NRAGE plays a vital role in this
pathway in that forced activation of NRAGE by over-expression leads to caspase
and p38 activation and apoptosis, whereas, eliminating or diminishing NRAGE
expression rescues cell viability in the presence of BMP. This places NRAGE as
a mediator in determining cell death in these progenitor systems.
XIAP as a Mediator of Cell Death

Since NRAGE is shown to be an activator of p38 that ultimately initiates
the cell death program, the question shifts to how is NRAGE regulated and
activated within the cell. NRAGE binds both TAKI and TAB1 leading to NRAGE
serine phosphorylation and ultimately initiation of apoptosis. This suggests that
NRAGE is a f ~ ~ l c r ubetween
m
apoptosis and survival and that when associated
with TAKI and TABI, NRAGE triggers death but regulated by contact with XIAP.
Therefore, unlike neurotrophin survival in which cells are at the brink of death
and compete for limited amounts of trophic support to quench the apoptotic
signals, BMP induced cell death is an instructive signal initiating a quiescent
apoptotic pathway.
Early Progenitor Cell Death

There appears to be two functionally distinct types of programmed cell
death in the developing nervous system of mammals. An early cell death limiting
the number of neural precursors and the more traditional mechanism of pruning
unnecessary and miss-routed post-mitotic neurons based on trophic support16.

Upper reports have suggested that up to 70% of cortical neuroblasts in the
proliferative ventricular zone undergo apoptosis, though the actual percentage
conceptually must be less than 50% in order to expand the neural epithelium.
Whatever the exact percentage is in murine and primate species this progenitor
apoptosis cornmences at E10, and peaking at -E13,

before decreasing

postnatally to low levels seen in the adult23s26s29*342*343.
This early-programmed cell
death coincides well with both the spatial and temporal distribution of NRAGE.
Given the evidence presented within, it seems logical that this early cell death is
mediated by the activa,tion of INRAGE by BlVlPs and potentially other TAKI, TAB1
activating factors, resulting in p38 activation and initiation of the caspase. Taken
together with the fact that NRAGE levels peak just prior to the onset of the
apoptosis described by Blaschke et al. This further supports the important role
that NRAGE plays in mediating cell survival in the early cortex.
NRAGE is a Required Element in Cell Cycle Withdrawal, Differentiation and
Apoptosis of Neural Progenitors.

Our findings presented within are in agreement with previous reports
demonstrating a collaborative effort between TAKI and TAB1 induced cell death
in the ventralization the Xenopus embryo2I4.The activation of TAKI requires an
association with TABI~*'.

Moreover, XlAP interaction with the cytoplasmic

domain of BMPR-la enhanced the ventralization of TABI-TAKA, but perturbed
the apoptotic

There is increasing evidence that this pro-apoptotic effect

is directly regulated by p38, not JNK activity, which antagonizes the survival
effects of FGF8-MAPK signaling required for neural progenitor survival421-424

Abrogation of NRAGE or TAKI expression leads to a decreased in p38 activation
and reduced cell death. It is tempting to speculate that the capacity for p38 to
challenge cells to undergo apoptosis is regulated in part by its ability to directly
phosphorylate Rb in a cdk independent manner399b401.
In this context p38 can
direct cells through the cell cycle leading to an enhanced G2-M arrest as a result
of active E2F-1 cell cycle

However, when NRAGE levels exceed a

specific cell context dependent threshold hlRAGE transitions from regulating
required cell signaling needed to mediate cell cycle withdrawal to facilitating
apoptosis of neural progenitors through cooperative actions of the apoptosis and
cell cycle machinery.
In addition to the capacity for p38 to regulate Rb inactivation, p38
stimulates myocyte enhancer factor 2 (NIEF2) family of transcription factors,
~ ~ - are
~ ~ ~ .
specifically MEF2A and IWEF2C, not MEF2B or M E F ~ D ~ MEFs

members of the MADS family of transcription factors originally identified as key
regulators directing myogenesis. They appear to function by physically
interacting with the basic helix-loop-helix (bHLH) myogenic transcription factor
MyoD and myogenin to promote muscle

Furthermore,

MEF2A and C are highly expressed in developing neural progenitors4I0 and
cooperate with the pro-neural bHLH transcription factor Mash1 during
n e u r ~ g e n e s i s ~ ~which
' - ~ ~ ~is, in agreement with our findings that NRAGE
knockdown prevents the transition of progenitor to post-mitotic neuron potentially
due in part to deficient MEF2AJC activation. During myogenesis the MEF2CMyoD complex requires the hypophosphorylated or active form of Rb as an

integral component to direct muscle development434and failure to so results in a
p2lwaf1-dependentapoptosisa5. Over activation of p38 leads to in excess of the
hyperphosphorylated Rb incapable of functioning in the MEF2-MyoD complex
promoting unscheduled re-entry into the cell cycle leading to apoptosis, whereas
insufficient p38 activity fails to generate adequate levels of active MEF2C
transcription factors thereby preventing the generation of the MEF2-MyoD
complex inhibiting differentiation of progenitor cells. Similar effects of p38 activity
are evident in our NRAGE gain and loss-of-function studies that demonstrate the
capacity for NRAGE to regulate the pleiotropic functions of p38 that ultimately
govern neurogenesis.
NRAGE Functions as an Important Link Between Differentiation and

Apoptosis.
Though there is no direct evidence to date that Rb binds and function as a
complex with MEF2-Mash1 transcription factors in neural progenitors, sufficient
circumstantial evidence exists that suggests a similar mechanism that directs
myogenesis may regulate neurogenesis. Neural progenitor undergoing BMP
mediated apoptosis

require elevated

p21

and

p27kip1

Furthermore, accumulation of non-apoptotic levels of p27kip1is required for BMPinduced growth arrest and neural
the

activity

MEF2C and

activity271 ,437,438

Rb

that is integrally linked to
promoting survival

under stringent

p38

CHAPTER 4
General Conclusions.

A requirement for neural progenitor differentiation is exit from the cell cycle

in which several proteins have been implicated in controlling the G I arrest, one
of which Necdin is a close family member to N R A G E ' ~ ~ Direct
* ~ ~ ~coupling
- ~ ~ ~of.
the cell cycle and death machinery regulating differentiation has been well
documented693440.
Unrestrained E2F activity as a result of loss of Rb function and
forces unscheduled re-entry into the. S phase of neural progenitors attempting to
arrest in G I , thereby promoting apoptosis through p53. The importance for Rb in
maintaining the G I arrest and thus cell survival becomes very apparent in ~ b - l null mice in which aberrant S phase re-entry results in a tremendous level of
apoptosis in the progenitor pool leading to embryonic lethality by E15.563-66 .
Though this apoptosis can be circumvented in conditional ~ b - ' null
mice under
the control of the Foxgl promoter441and explained in lieu of a model proposed
by Gail

arti in^^^

in which FGF8 activates the transcription factor Foxgl that

inhibits BMP mediated apoptosis in neural progenitors. Our gain and loss-ofNRAGE studies support the pinnacle roll, which Rb plays in maintaining survival
and differentiation of neural progenitors and positions p38 as a molecular switch
determining life or death.
Furthermore, the results presented within demonstrate that perturbation of
BMP signaling through NRAGE knockdown enhances both pro-neural and anti-

neural gene expression. This imbalanced gene expression, a direct result of loss

of p38 activity leading to prolonged .0ct314 and Hesl expression, is sufficient to
permit the transition from pluripotent stem cell to neural progenitor. However,
when these progenitors are challenged to differentiate into a post-mitotic cell, in
addition to cell cycle deficit's, they lack sufficient levels of MEF2AIC, which is an
integral component required to drive the later stages of neurogenesis. Should a
progenitor be exposed to high levels of BMP stimulation, NRAGE sustains
proliferation and re-entry into the cell cycle through direct yet transient coupling
of Rb phosphorylation by p38 kinase activity, which is functionally antagonized
via a prolonged Smad-NRAGE inhibition of c-myc and activation of p21Waf1and
p27kipl 403-405 . These apposing challenges on the cell cycle, all regulated ,through
BMPR, when in excess lead to the promotion of an NRAGE-p53 dependent
apoptosis. Therefore, NRAGE has the capacity to regulate progression through
the cell cycle and cell cycle arrest in an elegant cell context dependent manner
ultimately affecting the overt differentiation of the progenitor pool creating a
differentiation-coupled apoptosis (Fig. 21).

Figure 21. NRAGE Mediates Apoptosis of Neural Progenitors.
BNlP stimulation triggers activation of NRAGE and its cooperation with the
XIAP-TAKI-TAB1 complex to activate p38. Active p38 directly inactivates Rb,
thus promoting progression through the cell cycle. This precocious re-entry into S
phase leads to the activation of p53 that simultaneously facilitates activation of
p21Waf1,
promoting growth arrest and formation of the apoptosome resulting in
mitochondria1 leakage and caspase activation. The requirement for NRAGE

mediated growth arrest i s best demonstrated through loss of function in which
neural progenitors fail to differentiate, as terminal exit from the cell cycle is
perturbed.

However, crosstalk of the BMP signaling pathway with other signal transduction
pathways is becoming increasing more robust. Reciprocal modulation has been
described between Wnt (canonical and non-canonical), TGF-blactivin, Erk-MAPK
and the JAK-STAT pathway. An understanding of biological context in which
these signaling pathways intersect signifies the next major frontier. It is of
paramount importance to define NRAGE's role within this greater context of cell
biological signaling.

Wnt and BMP Siqnalinq Durinq Neuroqenesis.

Although a role for Wnt signaling in early dorsal-ventral patterning is well
established, Wnt signaling has only recently been shown to contribute to neural
induction and cell survival443.444. The Wnt signaling cascade includes the
secreted Wnt ligands, Frizzled receptors, and intracellular proteins such as
Dishevelled and glycogen synthase kinase 3 (GSK3). After activation of the Wnt
signaling pathways, GSK3 inhibition by Dishevelled allows stabilization and
nuclear localization of 0-catenin, complexes with TCF DNA-binding proteins to
activate transcriptional targets445.
Ectodermal

explants

from

Xenopus

can

be

induced

to

form

neuroectoderm through Wnt treatment or over-expressing the Frizzled receptor,

Dishevelled, a dominant negative form of GSK3 or a constitutively active form of
p - ~ a t e n i n However,
~~~.
.the most compelling data suggesting an important in vivo
role for Wnt signaling comes from mouse models over-expressing a constitutively
active form of p-catenin in the ectoderm resulting in expansion of the neural
progenitor pool, whereas a dominant-negative form of TCF blocks neural tissue
formation and promotes a p o p t ~ s i s Although
~~~.
it is not yet certain how Wnt
signaling exerts in neurulizing activity, this process may be mediated by
regulation of BMP expression. As noggin cannot down-regulate BMP4
expression during gastrulation, Wnt signaling can perform this function443. In
Xenopus, it has been suggested that the neural specifier (Xirol and Xiro2) that is
activated by Wnt signaling encodes a repressor that is essential for neural
~ ~ .
Wnt signaling seems to
development by down regulating B M P ~ In~ zebrafish,

play a more central role in neural patterning than in neural induction. Mutations in
the Wnt signaling pathway include headless (TCF3) and bozozok, a
homeodomain protein downstream of Wnt signaling448450.Embryos carrying
mutations in either of these genes have defects in anterior-posterior neural
patterning, but neural tissue is still induced. However, Wnt signaling is carefully
regulated and Wnt

antagonists are

needed to

promote telencephalic

development of the ANR. One of the secreted proteins responsible for the activity
of the ANR is TIC^^', a member of the secreted Frizzled Related Proteins (sFRP)
family. sFRPs are generally considered to antagonize Wnt activity by
sequestering secreted ~ n t s ~ This
~ * . suggests that the establishment of the
telencephalon requires local suppression of Wnt activity. Studies in Xenopus,

chick and mouse also suggest that the telencephalon is established in a domain
of low Wnt a ~ t i v i t y ~ The
~ " ~canonical
~~.
Wnt pathway is used reiteratively during
the development of the forebrain. Wnt signaling contributes to

initial

regionalization of the formation neural plate into crude AP subdivisions, then
locally promotes caudalization of the forebrain anlage and later still induces
proliferation and modulates patterning within individual forebrain domains.
Although these roles are now reasonably well documented, the mechanisms by
which Wnt and BMP signaling regulates regional fate determination within the
forming CNS are still poorly understood. However, there is evidence that BMP
and Wnt/p-catenin signaling directly interact in early Xenopus embryos, TAKI
activates a distantly related MAPK family member Nemo-like kinase (NLK); this
pathway culminates in the inhibitor phosphorylation of TCF-l/Lef-1 and the
down-regulation of Wntlp-catenin-inducible trans~ription~'~,~~'.
Therefore, it is
tempting to speculate that in addition to NRAGE-TAKA-p38 activity, NRAGE may
antagonize Wnt signaling through.direct coupling of NRAGE and NLK. Indeed, in
Drosophila and Xenopus, NLK is required for BMP mediated neurogenesis and
a p o p t o s i ~ Thus,
~ ~ ~ ~these
~ ~ ~novel
.
insights provide yet an additional level of
BMP-NRAGE mediated regulation of neurogenesis to explore.

FGF and BMP Siqnalinq During Neurogenesis.

The ability of Wnt antagonists to locally induce instructive FGF signals in
the A N R ~ suggests
~'
that establishment of the ANR, as a source of FGF signals
is a downstream consequent of local repression of Wnt activity. Secreted FGFs

signal to target cells by binding and activating cell-surface tyrosine kinase FGF
receptors ( F G F R S ) ~ ~Once
' ~ ~ ~an
~ .FGF ligand is bound, the receptor dimerizes
and phosphorylates intermolecular tyrosine residues, triggering initiation of FGFR
signal t r a n s d u ~ t i o n ~FGFR
~ ~ ~ ~ signaling
~.
activates a number of signal
transduction molecules, including those of the Ras-ERK and phospholipase C-y
pathways464.466-468
One of the most intriguing roles proposed for FGFs signals is to polarize
the telencephalon, with high levels of FGF activity promoting anterior cortical
fates4691470.
Specially, following neural tube closure, Fgf8 expression is localized

~ ' removal of the ANR or treatment with inhibitors of FGF
to the A N R ' ~ ~ . 'and
signaling causes loss of expression of telencephalic molecular markers, such as
~'
recently, through genetically elimina.ting, genetically
Foxg1 ( B ~ I ) ' ~ ' ~.~More
reducing or experimentally increasing Fgf8 expression in the forebrain a dose
dependent effect on cell differentiation and survival was observed442. In
particular, either eliminating or increasing Fgf8 expression increased apoptosis,
whereas reducing Fgf8 expression had the opposite effect and these result
where attributed to changing BNIP4 levels. In the telencephalon, FGF activity
may contribute to the polarization of the cortical territories in part through
repression of Emx2 transcription

The competence of adjacent

cells to respond to FGF signals may both be regulated by Six3 and Irx proteins.
Fgf8 expression in the ANR is dependent on Six3

and in a similar

way to Six3, Otx2 may confer the ability of the anterior neural plate to respond to
ANR signals. Indeed, the ANR of hypomorphic otx2 mutant mice is functionally

intact, but the neural plate of such embryos lacks the ability to respond to ANR
signals or exogenous F G F S ~ ~ ~ .
The ability of

FGF signaling to

regulate regionalization of the

telencephalon through suppression of high levels of BMP activity is an important
step in the establishment of the prospective forebrain475. However, with the
forming neural plate, lower levels of BMP activity contribute to the initial
establishment of the lateral to medial pattern. Consequently, specific thresholds
of BMP activity appear to be required for the commitment of fates that derive
from margins of the neural plate, such as telencephalon, dorsal eye, and
epithalamus r o s ~ t r a l l yand
~~~
dorsal
, ~ ~ sensory
~
neurons and neural crest cells
These observations suggest that a window of BMP activity during
neurogenesis enables development of marginal and dorsal neural fates. If BMP
signaling is too high, non-neural fates are promoted, whereas if it is too low, then
more medial neural plate fates are promoted. Thus establishment of the ANR
itself may depend upon rostra1 marginal neural plate cells being exposed to
appropriate levels of BMP

Indeed, the capacity for cortical

progenitors within the CNS to respond to BMPs is highly dependent on their
developmental age. During early neurogenesis of the cortex, E12, BMP4
promotes apoptosis3830481n482. Intriguingly, by E l 4 low doses of BMP4 are
required to promote neurogenesis within the dorsal neocortex and as the
concentration of BMP4 increases neural progenitors have a greater propensity
towards apoptosis

This BMP4-mediated apoptosis of early neural

progenitors is dependent on the transcription factors Msx2, ID2 and the CKI

~21Waf1436 . Collectively, these studies demonstrate that BMP4 is an important
switch between cell death and differentiation in a cell cycle dependent manner.
The capacity for FGFs to regulate the survival and differentiation of neural
progenitors is believed to occur through inhibition of excessive BMP signaling.
The ERK-MAPK pathway that mediates the effects of certain receptor tyrosine
kinases (RTKs) can also modulate the BMP-Smad pathway by regulating Smad
activity. Activation of RTKs by libands such as FGF or EGF stimulates ERK
mitogen-activated protein kinases. ERK in turn phosphorylates serine residues in
consensus PXSP motifs located within the MH1 and MH2 domains of ~ m a d 1 ~ ~ ~ .
This phosphorylation serves to inhibit nuclear accumulation of Smadl, although
the mechanism for this inhibition remains unclear. This mechanism may underlie
the observed opposing effects of mitogenic factors and BMPs during
development4847485,
thereby preventing growth arrest through perturbation of
nuclear translocation of NRAGE-Smad complexes. However, BMP and FGF
signaling can cooperate in certain contexts, such as bone and tooth
morphogenesis and erythroid differentiation486-489
The Smads are sometime referred to as "fast-track" molecules because
they can directly transduce a signal from the plasma membrane to the gene. The
JAK-STAT pathway also uses "fast-track" molecules, namely the STATS~".
Recently, evidence for cross talk between these two pathways has been
reported. Leukemia inhibitory factor (LIF), which acts through the gp130 receptor
and STAT3, can act synergistically with BMP2 in inducing astrocyte
This synergism has been shown to be due to the formation

of a Smadl and STAT3 complex bridged by the transcriptional co-activator
p300lCBP. Moreover, the synergistic effect of BMP4 and LIF, was recently
described as a mechanism for embryonic stem cell self-renewal through
antagonization of ERK and inhibition of TAKI-mediated activation of p38, that
consequently leads to the up-regulate of helix-loop-helix (HLH) inhibitor of
differentiation (Id) transcription factors and MSX~~''. A phenomenon recapitulated
in our NRAGE knockdown paradigm in which perturbation of NRAGE and thus
p38 activity was sufficient to trap NP in an undifferentiated state. The concept for
BMP facilitating stem cell self-renewal also applies to neural stem cells. In the
place of LIF signaling, activation of Notch plays a key role in keeping progenitor
cells from differentiating into neurons. BMP2 was shown to enhance neural
progenitor cell maintenance through Notch-induced transcriptional activation of
the basic-helix-loop-helix (bHLH) transcription factor Hesl and Hes5 in which
Smadl and IVotch intracellular domain complex with p300 promoting progenitor
gene t r a n s ~ r i p t i o n ~Collectively
~~.
these results highlight the increasing
awareness of the important contributions that HLH and bHLH transcription
factors play in the differentiation of neural proger~itorcells and the complex cross
talk mediated through BMPRs in which NRAGE regulating both growth arrest and
cell cycle progression ultimately affect the capacity of overt differentiation. Thus,
our results yield novel insights in the dynamic interplay NRAGE regulates
through BMP signaling directing stem cell self renewal, differentiation and
survival.
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